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        1. INTRODUCTION 
 
 
 
1.1  Melanogenesis 
 
Eye, hair and skin colour is one of the most obvious phenotype in individuals 
and it is the result of the presence and distribution of melanins. Melanins are 
complex pigments exclusively synthesized in a population of highly 
specialized cells including the epidermal and choroidal melanocytes (Hearing 
and Tsunkamoto, 1991) and the cells of the pigment epithelium of the retina 
(RPE), iris and ciliar body of the eye. Melanins tipically consist of copolymers 
of black and brown melanins (eumelanins) -unsoluble in all the solvents- and 
red and yellow melanins (pheomelanins) -soluble in alkalis and containing 
sulphur. 
Both types of melanins are synthesized in sequential reactions, initiated by the 
conversion of tyrosine to L-DOPA (Aroca et al., 1993), catalyzed by a key 
enzyme, Tyrosinase  (TYR), that mediates also the next oxidation of L-DOPA 
in dopaquinone (Hearing et al., 1992), (Winder et al., 1994); (Jimenez et al., 
1991). Pheomelanins are synthesized under certain conditions by subsequent 
reduction reactions requiring cysteine (Hearing et al., 1999). Eumelanins 
result from sequential oxidation and hydroxylation reactions, mediated in part 
by tyrosinase and the related enzymes, Tyrp1 and Tyrp2 (TRP1 and TRP2) 
(Jackson et al., 1992). Reactive indoles are the end-result of these reactions 
(Figure 1).  
Specialized cell types often require unique organelle to fulfil their specific 
function. Indeed, in pigmented cells melanin synthesis is confined within 
unique organelles termed melanosomes (Marks and Seabra, 2001). 
Sequestration within melanosomes protects component of the cytosol and 
other membranous organelles from oxidative attack during melanin synthesis, 
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and concentrates melanin for storage (in eye pigment cells) or cell transfer 
(from epidermal melanocytes to keratinocytes  in the skin and hair). 
Melanosomes transfer to keratinocytes provides colour but also 
photoprotection from ionizing radiations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The main steps of melanin biosynthesis. The enzymes (Tyrosinase, Tyrp-1 and DCT) 
that catalyze different steps of melanin synthesis are labelled in red. 
 
 
Melanosomes are not simply pigment-filled granules, but rather organelles 
that mature from unpigmented premelanosome to fully pigmented 
melanosomes through four morphologically distinct stages (Seiji et al., 1963) 
(Figure 2). 
The first stage is an endosomal intermediate containing internal vesicles -
similar to early multivesicular endosomes (MVBs)- in which amyloid-like 
fibers begin to form and organize in the typical striation of the stage II 
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premelanosomes (Piper RC, Luzio JP, 2001). Melanins begin to be deposited 
on the amyloid-fibers as they are synthesized, in stage III melanosomes, until 
the entire luminal space is filled, and the organelle reaches its final stage: 
stage IV. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 : Ultrastructural characterization of melanosomes. Electron microscopy analyses of a 
MNT-1 human melanoma cells (from Raposo and Marks, Nat.Rev.Mol.Cell., 2007). The four 
stages of melanosome development are shown also in detail in the lateral panels. Note the dense 
bilayered coat (arrowhead) and intralumenal vesicles (arrow) of stage I premelanosomes, the 
proteinaceous fibrils (arrow) of stage II, and the melanin deposition (black) in stage III and IV. The 
main panel shows a typical field of MNT-1 cytoplasm, which contain all four stages melanosomes. 
M, mitocondria. Scale bar represent 500 nm. 
 
 In eye pigment cells, stage IV melanosomes are retained and absorb stray 
light and probably trap free radicals (Futter C.E. 2006). In epidermal 
melanocytes, stage IV melanosomes are translocated  along microtubules from 
the cell centre to actin-rich dendritic tips, and then transferred in a still-
I 
II 
III 
IV 
III 
IV 
II 
I M 
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unresolved manner to neighbouring keratinocytes (Van Den Bossche et al., 
2006). Melanosome translocation in these cells involves bidirectional 
transport along microtubules, facilitated by both dynein and kinesin motors, 
and peripheral capture on actin filaments (Seabra M and Coudrier E. 2004). 
Capture on actin filament is mediated, at least in part, by a complex that 
consists of myosinVa, the small GTPase RAB27a and the linker protein 
melanophilin (Seabra M and Coudrier E. 2004).  
 
 
1.2 Melanosome composition and biogenesis 
 
Melanosomes are classified as Lysosome Related Organelles because of their 
shared features with lysosomes such as: acidic pH, presence of Lysosomal 
membrane proteins and lysosomal hydrolases, accessibility to endocytic 
tracers. Nevertheless these organelles have distinct morphological and 
functional features that are likely to be acquired during their biogenetic 
process. Melanosomes generate by a multistep process in which an immature 
organelle forms within the endocytic system and matures by acquisition of 
additional cargo and effectors proteins. Although they find their origin within 
the endocytic pathway they coexist and remain distinct from conventional 
bona fide late endosome/lysosomes (Raposo et al., JCB 2001).  
The melanogenic enzymes and structural components of melanosomes (Box 
1) are synthesized by pigment cells and must be appropriately targeted to the 
newly forming melanosomes. Most known components are integral membrane 
proteins that are uniquely expressed in pigment cells, and mutation in the 
genes that encode them often cause albinism in humans or coat-colour dilution 
in animals (Bennett D.C. et al, 2003). For example Pmel17 serves as the 
structural foundation of the fibrils in stage I and II melanosomes, whereas the 
melanin biosynthetic enzymes Tyrosinase, Tyrosinase-related protein and 
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DOPAcrome tautomerase (DCT) are enriched in stage II and IV melanosomes 
(Raposo et al. 2001; Theos et al. 2005). Melanosomes also harbour ubiquitous 
components of lysosomes and late endosomes, one example is Lamp-1 (Orlow 
S.J., 1995; Chi A. et al., 2006). Melanosomal proteins must be also 
appropriately sorted from the macromolecules destined for conventional 
lysosomes.  
Studies in skin melanocytes from the human patients or mouse models for 
these pigmentary disorders (e.g. Hermansky Pudlak Syndrome (HPS), a 
complex genetic disease in which melanosomal protein sorting is defective 
(Wei M.L., 2006)) begun to elucidate the cellular and molecular mechanisms 
involved in the trafficking of melanosomal matrix proteins and melanosomal 
enzymes. All these studies lead to propose a model (Figure 3) in which 
melanosome biogenesis requires firstly the generation of unpigmented 
premelanosomes and their Pmel17 driven intraluminal fibers and secondly the 
transfer of the key enzymes involved in melanin synthesis (Tyrosinase and 
Tyrp1) (Raposo et al. 2001). In the first event, the transmembrane protein 
Pmel17 is sorted in endosomal compartments with hallmark of MVBs (Berson 
et al., 2001; Berson et al., 2003). Pmel17 sorting to the intralumenal vesicles 
does not require ubiquitination and is not dependent on the ESCRT machinery 
(Endosomal Sorting Complex responsible for Transport) (Theos et al., 2006) 
involved in MVB biogenesis (Williams et al., 2007). In these MVBs, Pmel17 
is cleaved by a prohormone convertase liberating a fibrillogenetic fragment in 
its luminal domain, which leads the generation of the striations by a still 
poorly understood mechanism (Berson et al., 2003). Once premelanosomes 
are formed, melanogenetic enzymes are transferred to the maturing organelle. 
It has been recently shown that Tyrosinase traffics through the early endocytic 
pathway to the maturing melanosome and its sorting requires the recognition 
of its cytoplasmatic tail by two heterotetrameric adaptors AP-3 and AP-1 
(Theos et al., 2005). Altogether these studies indicate that multiple sorting 
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events participate to the creation of the optimal environment for the 
melanogenesis, the targeting of melanosomal components and the 
maintenance of melanosomal identity (Raposo and Marks, 2007). The 
biosynthetic and endocytic transport in melanocytes requires requires a tight  
regulation by ubiquitous mechanisms of trafficking (Adaptors, SNAREs, 
small GTPases of the Rab superfamily) but also additional levels of 
specialization that are fulfilled by other proteins with still unknown functions 
in which mutations affect pigmentation (e.g. Biogenesis of Lysosome-related 
Organelles Complexes -BLOCs- mutated in HPS) or by the melanosomal 
protein themselves (Raposo et al., 2002). 
       
 
Figure 3: Model for melanosome maturation (from Raposo and Marks, Nat.Rev.Mol.Cell., 2007). 
Schematic diagram of endosomal and melanosomal stages, and the biosynthetic transport pathways 
among them for three representative melanosome cargoes – PMEL, tyrosinase and tyrosinase-
related protein-1 (TYRP1). The divergence of endocytic cargo that is internalized by fluid phase 
and destined for lysosomes is also shown. Transport pathways for each cargo are indicated by solid 
or dashed lines as indicated in the key. All melanosome cargoes derive from the Golgi and traverse 
vacuolar and/or tubular elements of early endosomes either directly or through the cell surface. 
From vacuolar elements, PMEL fibrils (green) segregate to stage II melanosomes, and endocytic 
cargo segregates to late endosomes and eventually lysosomes. From tubular elements of early 
endosomes, tyrosinase and TYRP1 are targeted to maturing melanosomes where they promote 
melanin deposition (orange). Adaptor protein-3 (AP-3) coats initiate one endosome-to-melanosome 
pathway for a cohort of tyrosinase; biogenesis of lysosome-related organelle complex-1 (BLOC-1), 
BLOC-2 and perhaps AP-1 regulate a second pathway that is traversed by a separate cohort of 
tyrosinase and by TYRP1.  
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1.3 Albinism 
 
The melanogenic function of pigmented cells can be altered in some inherited 
and acquired disorders, with consequent hypopigmentation. In addition to the 
serious esthetical problems, the melanocyte malfunction may expose the skin 
to the dangerous effects of UV radiations and increase the risk of melanoma 
(Sober, 1991). The “pigmentation diseases” include a wide heterogeneous 
range of pathological conditions. Among these, albinism –a genetical disease 
with a frequency of 1:20000 births- comprises a group of hereditary 
conditions in which the skin, hair and eye pigment cells show an altered 
melanin synthesis and/or distribution. Albinism was one of the first genetic 
inherited diseases to be noted in humans (for the obvious hypopigmented 
phenotype of hair, eyes and skin), but until relatively recently, little was 
known about the molecular mechanisms involved in its pathogenesis. 
Mutations in at least five different genes (Box 1) can cause a reduction in 
melanin pigment biosynthesis, producing the various clinical features 
associated with albinism, including hypopigmentation of the skin, hair, and 
eyes; optic tract misrouting; foveal hypoplasia; and reduced visual acuity.   
Two main categories of albinism have been described:  
• Oculocutaneous albinism (OCA), whose phenotypical alterations    
             affect skin, eyes and hair 
• Ocular albinism (OA), that involves primarily the eyes, while skin  
             and hair appear normal. 
There are several types of oculocutaneous albinism (and multisystem 
disorders characterized by partial albinism) while there is only one major type 
of ocular albinism. Many genetic loci that affect melanosome function have 
been identified by their phenotype in mice with coat colour dilution or in 
human OCA patients. The function of the proteins affected in albinism is 
strictly related and specific to melanosome function, in fact are all expressed 
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only in pigment cells. In the mouse mutations have been found in ubiquitous 
proteins involved in the motility (rab27/myosinV)  (Seabra M and Coudrier E. 
2004) and/or formation of melanosomes (P, Matp) and other LROs in various 
tissues (Wei et al., 2006). A correlation with pigment defects in humans is still 
under investigation for these latter proteins. 
Only one gene mutated in Ocular Albinism (OA) patients has been cloned so 
far and is called OA1 (GPR143) (Bassi et al. 1995). 
 
    Box 1:            PIGMENTATION GENES AND THEIR PROTEINS. 
Gene Mouse model Disease Protein/function melanosomal defect 
TYR 
 
Albino (c) 
 
OCA1 
 
Tyrosinase  
Melanin enzyme 
 
-Absence of melanin 
-Melanosome block at stage II 
 
TRP1 
 
Brown (b) 
 
OCA3 
 
TRP-1  
Melanin enzyme 
 
-reduction of melanin content 
 
MATP 
 
Underwhite (uw) 
 
OCA4 
 
MATP 
Putative membrane 
transporter 
 
-hypopigmentation due to an 
abnormal trafficking of  
Tyrosinase 
-Small and irregular 
melanosomes blocked  
at stage III 
 
P 
 
Pink-eyed dilution (p) 
 
OCA2 
 
P-protein 
Putative anion  
transporter 
-reduction of melanin content 
-alteration of melanosome 
architecture 
-mislocalization of melanin 
 enzymes 
 
OA1 
 
Oa1 KO 
 
OA1 
 
OA1  
Intracellular GPCR 
 
-Pigmented 
macromelanosomes 
 
 
 
Mouse models of pigmentary disorders have been of great value for the 
elucidation of the molecular mechanisms underlying the biogenesis of 
melanosome. Hermansky-Pudlack syndrome (HPS) is one example of another 
kind of human pigmentary disease that have helped to highlight novel 
trafficking steps operating in specialized cell types by the study of its several 
mouse models. HPS is a complex disorder characterized by partial albinism 
and bleeding defects, lung fibrosis and ceroid accumulation in lysosomes and 
major defects are observed in melanosomes and platelet dense granules (Wei 
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M.L., 2006). HPS results from mutations in any of at least eight genes, and a 
similar disorder in mouse results from mutations in at least 15 different genes. 
Most of the genes encode subunits of multimeric protein complexes. Some of 
the complexes, such as the adaptor protein complex AP3, that are known to be 
involved in vesicular transport, are also involved in the sorting of 
melanosomal cargo, whereas others, such as the biogenesis of lysosome-
related organelles complex-1 (BLOC-1, BLOC-2 and BLOC-3), that consist 
of a subunits that lack common structural motif or homology to protein of 
known function, give specificity to this transport. In fact cargo sorted by AP3 
is destined for late endosomes and lysosomes in several cell types; instead, in 
pigment cells, tyr and tyrp-1 are destined for melanosomes, which indicated 
that additional effectors must participate in their sorting. Some of these 
effectors may include BLOCs and other complexes that are also defective in 
HPS (Wei et al., 2006; Di Pietro e Dell’Angelica, 2005). 
 
 
1.4 Role of components of the secretory system in melanosome biogenesis. 
 
The secretory system of eukaryotic cells is organized as a series of membrane-
enclosed compartments that include the endoplasmic reticulum (ER), Golgi 
cisternae, the trans-Golgi network (TGN), various types of secretory vesicle 
and the plasma membrane (Bonifacino et al., 2004). This system interconnects 
at several junctures with the endosomal-lysosomal system, another array of 
membrane-enclosed compartments, that comprise different types of 
endosomes (for example, early, late and recycling endosomes) and lysosomes, 
as well as cell-type specific lysosome-related organelles (for example, 
melanosomes). Newly synthesized proteins that are destined for secretion into 
the extracellular space or for residence within organelles of the secretory and 
endosomal-lysosomal system move from the ER to their final destinations. 
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This outward flow is counterbalanced by an influx of protein that follow the 
endocytic pathway and by various retrograde-transport pathways. Among the 
organelles of the secretory pathway the TGN has a central role as a site of 
protein sorting (Griffiths et al., 1986) (Bonifacino et al., 2004). Once proteins 
coming from the ER reach the TGN, the TGN sorts them to each of their 
possible destinations (extracellular space, different domains of the plasma 
membrane, secretory vesicles and endosomes) into specific sets of membrane-
enclosed carriers. This role of the TGN as a traffic hub is not limited to 
forward-transport pathways, because the TGN also receives proteins by 
retrograde transport from more distal organelles, most notably endosomes 
(Rohn et al., 2000). The movement of proteins between these different 
compartments is a highly regulated process mediated by many different 
factors, including SNARE and SNARE attachment proteins (Gerst, 1999), 
small GTP-binding proteins (Pfeffer, 1996) and vesicle tethering factors 
(Whyte and Munro, 2002). Tethering factors can be categorized as long, 
coiled-coil proteins (e.g. GM130/Golgin-95) or multisubunit protein 
complexes (e.g. TRAPPI, II and COG) that physically link the vesicles and 
the target membranes upstream of membrane fusion and are believed to 
significantly contribute to the specificity of the transport reaction (Lowe, 
2000; Whyte and Munro, 2002). How the different types of tethering factors 
contribute to the overall specificity of this process is presently unknown. 
Recently, a new mouse model, for mosaic hypopigmentation (mhyp) has been 
identified, in which the mutated gene is Trappc6, a subunit of the TRAPP 
tethering complex, that has been implicate in control of pigmentation and 
melanosomal size. In fact Trappc6 mutant RPE shows patchy areas of 
depigmentation and irregular smaller, incompletely melanized, melanosomes 
(Gwynn B. et al., 2006). Trappc6, the mammalian homologue of the yeast 
trs33, is a subunit of the TRAPP (transport protein particle) I and II 
multiprotein complexes (Figure 4), required for tethering ER-derived vesicles 
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to Golgi membranes (Figure 5) and for Golgi traffic (Cai et al. 2005, Sacher et 
al. 1998, 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Model for the conserved structure and function of the TRAPPI and TRAPPII 
complexes in yeast (from Cox et al. 2007). TRAPP complexes mediate exocytic trafficking from 
the ER, trough the Golgi, to the plasma membrane. The TRAPPI complex (left) is shown as a 
quadrilateral with subunits indicated as triangolar sections. Subunits are 3-Bet3, 5-Bet5, 20-Trs20, 
23-Trs23, 31-Trs31, 33-Trs33. The TRAPPII complex (right) includes all the TRAPPI components 
plus the three TRAPPII-specific subunits shown in the trapezoidal shape above TRAPPI. In both 
complexes, subunits essential for viability are labeled in black letters, while non-essential subunits 
are shown in grey letters. Functionally, TRAPPI is the GEF (Guanine exchange factor)  for Ypt1 
(homologue to the mammalian Rab-1), the GTPase that regulates entry into the Golgi, wherease 
TRAPPII is the GEF for Ypt31/32, the GTPases that regulate exit from the Golgi (Morozova et al., 
2006).  
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Figure 5: a model for the action of TRAPP I in the ER-Golgi compartment (from Kim et al. 
2006). A transport vesicle is first captured at a long distance by long, coiled coil proteins (p115, 
GM130) (step 1). A bending motion in the nonhelical region of the coiled-coil protein brings the 
vesicle into close proximity to TRAPP I (step 2), which is anchored to the Golgi by an as yet 
unidentified mechanism. Upon recognition of an unidentified factor on the surface of the vesicle, 
the transport vesicle is more tightly tethered to the Golgi. Activation of Rab1/Ypt1p (step3) leads to 
recruitment of effector molecules (SNARE protein, e.g. stx5) to eventually enable fusion.  
 
While TRAPP complexes are essential for ER-to-Golgi and intra-Golgi 
vesicle trafficking in yeast, TRAPP subunits participate in additional events in 
mammals, including post-Golgi transport. In fact, another subunit of the 
TRAPP complex, Trappc4, is found in the spines of neural dendrites in 
mouse. Here it is thought, with other proteins, to recruit intracellular vesicles 
to postsynaptic sites (Ethell et al. 2000). However a recent study has shown 
that mutation of some of the TRAPP subunits impair cargo retrieval from 
early endosomes to the TGN also in yeast (Cai et al., 2005). Together these 
data indicate that TRAPP subunits play a role in multiple vesicular transport 
events and perform specific critical functions beyond generalized ER-to-Golgi 
transport. In particular, the mhyp phenotype implicates for the first time a 
TRAPP subunit, Trappc6a, in melanosome biogenesis. There are also other 
complexes similar to TRAPP, like the COG complex which primary function 
is intra-Golgi transport.  Interestingly, mutations in some subunits impair also 
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retrograde transport from both early and late endosomes to the TGN (Ungar et 
al., 2006). The yeast homolog (Sed5p) of Syntaxin-5, a t-SNARE protein 
important for vesicle transport and fusion between ER-Golgi, interacts with 
one TRAPP subunit and some COG subunits in yeast (Barrowman et al., 
2000). Moreover syntaxin-5 is also required in transport events from early 
endosomes to the TGN (Tai et al. 2004).  
 
 
1.5 Ocular Albinism Type 1 (OA1): the disease 
 
Ocular Albinism type 1 (OA1) represents the most common form of ocular 
albinism, with an estimated prevalence of 1:50000. This disorder is 
transmitted as an X-linked recessive trait, with carrier females showing only 
minor signs of the disease. Affected males with OA1 exhibit optic 
abnormalities typical of all forms of albinism, including severe reduction of 
visual acuity because of fovea hypoplasia, nystagmus, strabismus, 
photophobia, iris translucency, hypopigmentation of the retina, and misrouting 
of the optic tracts, resulting in loss of stereoscopic vision (King et al.1995). 
Most female carriers for OA1 can be clinically identified by a typical mud 
splattered mosaic pattern of depigmentation in the periphery of the ocular 
fundus (Lang et al., 1990), suggesting that the OA1 gene is subject to X-
inactivation. Therefore diagnosis is based on the X-linked transmission and on 
the ophthalmologic examination of the ocular fundus in the patient’s mother. 
As in other forms of albinism, the OA1 patients manifests an alteration of the 
optic tract due to a misrouting of the optic fibres at the chiasm. In the normal 
mature and pigmented eye the retinal ganglion cells axons originating from 
the nasal region of the retina cross the chiasm and are projected to the 
opposite (contralateral) side of the brain. Instead the fibers originated from the 
temporal retina do not cross the chiasm and are projected to their own 
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(ipsilateral) side of the brain (Figure 6). The divergence of these fibers begins 
early during eye development, at embryonic day E15.5. In the human adult 
eye the contralateral-ipsilateral fibers ratio is  about 55:45. This ratio is 
important for the overlap of the ocular fields necessary for the stereoscopic 
vision. In albinism this ratio is altered: a large proportion (>90% in some 
forms of albinism) of optic fibers originating in temporal retina cross the 
midline at the chiasm and project to the contralateral hemisphere, hampering 
stereoscopic vision in the albino patients.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Schematic diagram of the visual field. The fibers from the nasal retina cross 
over at the optic chiasm and project to the contralateral side of the brain (lateral geniculate 
bodies and superior collicoli), whereas the fibers from the temporal retina, arrive at the 
chiasm and then do not cross, but are projected to their own side.  
 
 
 
These features are common to all forms of albinism, including ocular albinism 
type 1 (OA1). Differently to the oculocutaneous albinism (OCA) in which 
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pigmentation is strongly affected, Oa1 patients display minimal cutaneous 
changes and mild hypopigmentation of skin and hair is found only in rare 
cases. Nevertheless, microscopic examination of melanocytes, in both retinal 
pigment epithelium (RPE) and in the skin, reveals the presence of large 
pigment granules called giant melanosomes or macromelanosomes. The 
macromelanosome phenotype suggest that the OA1 phenotype is not due to an 
impairment of melanin synthesis, but to a defect in the melanin biogenesis 
(Garner and Jay, 1980) (Yoshiike et al., 1985). This idea it is strongly 
supported by the phenotype analysis of knock-out mice for Oa1, displaying 
the same defects as the patients, such as misrouting of the optic fibers at the 
chiasm, hypopigmentation of the fundus and macromelanosomes in the RPE 
(Incerti et al., 2000) (Figure 7). 
 
 
 
 
 
            
 
 
 
                                                  (a)                                         (b) 
Figure 7. Hystological analysis wild-type (a) and Oa1 knock-out (b) mouse RPE. Oa1 
knockout RPE displays hypopigmentation and presence of giant melanosomes (red arrows). 
F: photoreceptors 
 
  
 
 
 
 
  
P
h
h
h 
P 
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     1.6 OA1 gene and its regulation 
 
The gene responsible for ocular albinism was isolated by a classical positional 
cloning strategy from the distal short arm of the X chromosome (Bassi et al. 
1995). In OA1 patients were found missense, nonsense mutations and 
deletions were found, suggesting that Ocular albinism type 1 is caused by 
“loss of function” disease. A recent study has identified a novel intronic point 
mutation in a family with this form of albinism. The mutation creates a new 
acceptor splice site in intron 7 of the OA1 gene, leading to the formation of an 
aberrant spliced mRNA, unstable, that contained a premature stop codon 
(Vetrini et al., 2006).  
OA1 transcript is expressed exclusively in pigmented cells of skin and eye, 
and in melanoma, consistent with the clinical phenotype of the disease. The 
murine Oa1 gene starts to be transcribed in the RPE at early stages of eye 
development (E10.5 in mouse eyes) and continues to be expressed until 
adulthood in pigment cells of the eye (Surace et al., 2000) (Figure 8).  Oa1 
transcript is also expressed in neural crest derived melanocytes. Similarly to 
other forms of oculocutaneous albinism, Oa1 expression starts before the first 
melanin deposition. Indeed the albinism genes show common mechanisms of 
regulation at transcriptional level. 
Oa1 expression is regulated similarly to that of melanogenic enzymes, such as 
tyrosinase (Tyr). In fact expression of Oa1 parallels temporally and spatially 
that of Tyr during development, and is regulated by the transcription factor 
Mitf (Vetrini et al., 2004). 
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    Figure 8. Oa1 expression in mouse RPE at different developmental stages: at 
embryonic days E10.5 and E11.5), at birth (P0) and in hair follicoles.  Arrow: OA1 
transcript in RPE.    
   
 
1.7 OA1 protein: structure and localization 
 
The protein product of the OA1 gene is a pigment cell specific membrane 
glycoprotein of 404 aminoacids, displaying seven transmembrane domains 
and structural homology with G protein-coupled receptors (Innamorati et al. 
2006, Schiaffino et al., 1999).  
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Considering that GPCRs belonging to different families do not share major 
primary sequence similarities, but rather a common three-dimensional 
structure that requires the presence of critical residues at precise positions 
(Gether, 2000; Pierce et al., 2002), the sequence homologies between OA1 
and GPCRs viewed in the context of the seven spanning membrane topology 
are highly significant. Alignment between OA1 and these receptors indicates 
that it is equally distant from all three families, possibly defining a new GPCR 
subfamily (Schiaffino et al. 1999). In addiction, orthologs of OA1 have now 
been identified in several species. OA1 is significantly conserved in 
mammals, birds, amphibians and fish, particularly at the N-terminus and from 
the third to the seventh transmembrane domains, while the C-terminal tail 
displays higher divergence (Schiaffino et al. 2005). 
The endogenous OA1 protein was characterized by western immunoblotting 
in normal human melanocytes extracts as a doublet of 45 and 48kD and a 
broad band of 60 kD. Studies in both melanocytes and transfected COS7 cells 
established that the 45 kD band corresponds to the OA1 protein backbone, the 
48 kD polypeptide to a yet unknown post-translational modification, and the 
60 kD band to the N-glycosylated form of both the former protein species. 
Glycosylation of OA1 protein initiates in the endoplasmic reticulum (ER) and 
is completed in the Golgi apparatus (D’Addio et al.2000). OA1 appears to be 
an integral membrane glycoprotein of the exocytic pathway, consistent to its 
homologies to GPCRs.  
The endogenous OA1 was found to co-immunoprecipitate with heterotrimeric 
G-proteins in melanocyte extracts and in particular the third cytosolic loop 
and the C-terminal tail of OA1 are able to bind Gα-inhibitory proteins by in 
vitro binding assays (Schiaffino et al. 1999). These functional findings suggest 
that OA1 behaves as a canonical GPCR.  
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OA1 is localized to the membrane of an intracellular organelle, the 
melanosome. However some controversy exist on the precise subcellular 
localization of the protein. In fact studies carried out on human melanoma cell 
line MNT1 showed the localization of endogenous OA1 to the membrane of 
melanosome at early and later stages of maturation. While studies on mouse 
melanocytes by using the recombinant OA1-enhanced green fluorescent 
protein (EGFP) did not allowed for a proper localization of OA1. In these 
latter studies OA1 was not detected in the membrane of melanosome but only 
in the endo-lysosomal compartment (Samaraweera et al., 2001). This 
discrepancy might be due to the different techniques or cell line used. 
Interestingly, in contrast to previously characterized GPCRs and to other 
melanosome proteins (Raposo et al. 2001), OA1 does not translocate through 
the plasma membrane. This is a unique feature for a GPCR. In fact, OA1 
represent the first example described so far of an exclusively intracellular 
GPCR, that mediates signal transduction from the organelle lumen to the 
cytosol. 
 
 
 
     1.8 The OA1 function: an unresolved question 
 
The exclusive intracellular localization of OA1 and its accumulation into 
specialized organelles such as the melanosomes are exceptional among GPCR 
and suggest that OA1 might transduce information from the organelle lumen 
to the cytosol to regulate proper melanosome biogenesis.  OA1 could function 
as a “sensor” of melanosome maturation and control the organelle growth, 
triggering a signal transduction cascade mediated by inhibitory G-protein Gαi.  
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The OA1 intralumenal ligand is not known, but it may consist of melanin 
itself or melanin precursors and intermediate products.  
Alternatively, OA1 might be activated by less conventional mechanisms, such 
as organelle enlargement, which in the absence of OA1 signalling could lead 
to macromelanosome formation. Finally, it cannot be excluded that OA1 
behaves as a constitutively active receptor and, therefore, that its ligand 
actually acts as an inverse agonist or inhibitor. 
The downstream pathway triggered by OA1 remains mysterious and at the 
present can only be hypothesized based on the consequence arising from the 
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loss-of-function of the receptor in humans and mice. The histological 
hallmark of OA1 loss of function is the presence of macromelanosomes in 
pigmented cells of eyes and skin. The Oa1 knock-out (KO) mice, showing the 
presence of giant melanosomes in RPE and in skin melanocytes, represent a 
good model for the study of the molecular consequences derived from lack of 
OA1. In these mice macromelanosomes are first detectable after birth and 
their number increases progressively until adulthood (Incerti et al., 2000). The 
observation of a single core melanosomes within the giant pigmented 
organelles and the absence of intermediates of melanosome-melanosome 
fusion claim against the idea that macromelanosomes derive from fusion 
between individual organelles. In contrast, they suggest an origin by abnormal 
overgrowth of apparently normal mature melanosomes, which are unable to 
control their final size and progressively grow by addiction of new melanin 
and membranes (Incerti et al., 2000). Based on these results OA1 appears to 
play an inhibitory role restricted to the final stages of melanosome maturation, 
modulating the resources (enzyme, membranes, melanin precursors) allocated 
to developing melanosomes via membrane traffic. Nevertheless, the function 
of Oa1 during melanosomes maturation is still obscure. As its downstream 
pathway, the role of OA1 in the development of the visual system is poorly 
understood. The misrouting of the optic tracts, at least in the mouse, develops 
much earlier in embryonic life (between E12.5-E16) than the appearance of 
macromelanosomes. Therefore the giant organelle might represent only an 
epiphenomenon of the disease and cannot be the direct cause of the optic 
nerve defect, which must be caused by some other alteration of the 
melanogenic process. In contrast to other forms of albinism, melanin is not 
dramatically reduced in ocular albinism, which is characterized by the unusual 
coexistence of the typical albino visual defects and the presence of melanin in 
the eyes (O’Donnell et al., 1976). The possibility that OA1 functions as a 
melanin receptor suggests that this protein might represent the missing link 
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between melanin deficiency in oculocutaneous albinisms (OCA) type 1 and 2, 
and the severe developmental abnormalities of the visual system observed in 
all types of albinism. Therefore the identification of the ligand of OA1 and 
unravelling of its downstream pathway could lead to crucial insight on both 
melanocyte biology and retinal development. 
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                                       2. AIM OF THE PROJECT 
 
OA1 is a unique G-protein coupled receptor (GPCR) that does not translocate 
through the plasma membrane but lays in intracellular membranes most likely 
melanosomes, mediating signaling transduction from the organelle lumen to 
the cytosol. Neither the intraluminal ligand nor the downstream pathways are 
known. OA1 gene mutation causes an X-linked disease, Ocular Albinism type 
1 in which the patients manifest a defect in the eye and in the skin. Among the 
other defects they show depigmentation of the fundus in the eye and the 
presence of abnormally giant melanosomes called macromelanosomes in the 
Retinal Pigment Epithelium (RPE) and in skin melanocytes. In our lab a 
knockout mouse model for this form of albinism was generated. As in OA1 
patients the Oa1 null mouse shows the presence of macromelanosomes in the 
RPE after birth. The macromelanosome phenotype suggests that Oa1 may 
function as a “sensor” of melanosome maturation. Nevertheless, OA1 
function in melanosome biogenesis and its downstream pathway are still 
elusive, hampering development of a cure for this form of albinism. 
Furthermore, the correlation between macromelanosome and the 
hypopigmentation of the RPE that causes the albinism phenotype in patients is 
unclear. 
In order to understand why mutation of OA1 causes albinism, during the first 
years of my PhD work I focused my research interest in addressing OA1 
function in pigment cells in vivo, by applying genetic approaches.  
We have taken advantage of the OA1 null mouse in combination with other 
albinism mouse models (Tyr c-2j and Matpuw) to study the function of OA1 in 
the RPE in vivo during development and after birth. We chose Tyr and Matp 
mutants because these mutant mice displayed impaired maturation of 
melanosomes. Tyrosinase mutant mice completely lack melanin and their 
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melanosomes do not develop beyond stage II (Costin et al. 2003). In Matp 
mutant mice melanosomes stop maturation at stage III (Sweet et al. 1998). 
Therefore, these two mouse models provided us with genetic tools to study 
OA1 function either in the absence of melanin or in impaired melanosomal 
maturation conditions. The phenotype of the double mutant mice compared 
with single mutants led us to the hypothesis that OA1 perform two functions 
in melanosome biogenesis. In particular, Oa1 loss of function causes a 
reduction in the number of melanosomes in the RPE, suggesting an OA1 
control of the rate of melanosome biogenesis. In addiction, double mutant 
phenotype analysis unraveled a size-control function of OA1 on the final 
maturation stage of melanosomes. Although our finding indicated that OA1 
regulates melanosome maturation and size, the trafficking events that lead to 
the macromelanosome phenotype were far from being elucidated. In a first 
attempt to elucidate these events I joined, during the last year of my PhD, 
Graça’s Raposo “Structure and Membrane Compartments” group at the 
CNRS-UMR144 hosted in the Institut Curie in Paris. In this group I had the 
appropriate environment to study OA1 function in pigmented cells in vitro by 
applying cell biology approaches. We started with investigation of OA1 
localization at ultrastructural level in melanocytic cell lines to identify the 
subcellular compartments at which OA1 could act. Then we have analyzed in 
detail the phenotype of Oa1 null melanocytes, that display 
macromelanosomes. In parallel we went on through a strategy of inactivation 
of OA1 in vitro to follow the progression of the events leading to the 
macromelanosome defect. Our data indicated that in the absence of OA1 there 
is an alteration of the trafficking of melanosomal protein and also of other 
proteins that normally are present in low amounts in melanosomes, suggesting 
a function for OA1 in maintaining melanosomal identity and composition. 
Although the phenotype of inactivated melanocytic cells deserves further 
analysis, these observations suggest that OA1 signaling ability may regulate 
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fusion or fission events between an intracellular compartment and 
melanosomes during their maturation. 
An interesting aspect that we wanted also to investigate was the link between 
the trafficking events regulated by OA1 and its downstream pathway. 
Taking advantage of a microarray analysis on murine embryonic eyes from 
wild type and Oa1 mutant mice we have identified interesting genes, that are 
involved in vesicle trafficking and are upregulated in OA1 mutant pigment 
cells. Our preliminary data suggested that Oa1 might function through 
regulation of proteins that regulate vesicle trafficking.  The study of this 
interaction during melanosome biogenesis is a first step towards unraveling 
the mechanism through which Oa1 affects melanosome number and size and 
thus better understand the pathological condition.  
 
 
 
              3.RESULTS 
 
 
3.1 Effects of Oa1 loss of function on Tyrosinase activity and the rate of 
melanosome biogenesis in the RPE 
Differently to other forms of albinisms in which melanin is absent (e.g. TYR) 
or reduced (e.g. MATP), in Oa1 loss of function melanin appears to be 
synthesized, as suggested by pigmentation of skin and hairs in patients. 
However OA1 patients present hypopigmentation of the ocular fundus and 
this cannot simply be explained by the giant melanosomes phenotype. 
To quantify this observation we measured the abundance and the activity of 
Tyr protein on Oa1 knock out eyes. 
We started by measuring tyrosinase quantity by western blot in protein 
extracts from embryonic E12.5, E14.5, E16.5 and postnatal P0 and P7 Oa1 
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KO and wt mice eyes and we found no significant difference at all these 
stages (Figure 9A).  
Then we measured the activity of tyrosinase in eye protein extracts from the 
Oa1 KO, heterozygous, and wild type mice 7 days after birth (P7) and found 
no significant difference among the different genotypes (Figure 9B). 
                     
          
 Figure 9. (A) Tyrosinase protein detection by western blotting in embryonic E12.5, E14.5, E16.5, 
and postnatal P0 and P7 wild type and Oa1-/- mutant eyes. Anti β-tubulin was used as a control to 
normalize protein amount. (B) Tyrosinase activity assay on eyes at the age of 7 days after birth. 
ANOVA confirmed no significant difference in the enzymatic activity among wt (n=9), Oa1 
eterozygous (n=9) and homozygous (n=6) mice. Tyrosinase activity in albino control CD1 mice 
was significantly different from that in wt (t-test P‹0.001). Data are shown as the mean divided by 
the blanc (CD1 mice have a value close to 1, therefore activity equal to blanc). 
 
Therefore, in contrast to other albinism models (LaVail et al.1978), lack of 
Oa1 does not impair either the quantity or activity of tyrosinase enzyme in the 
eye, suggesting a role of Oa1 not on melanin formation, but on melanosome 
biogenesis. It is possible that albinism in OA1 is due to a decreased 
abundance of melanosomes in the RPE. 
We have performed, in collaboration with Prof. C. Tacchetti at University of 
Genova, ultrastuctural analysis by electron microscopy to evaluate density 
(number of organelles per square micrometer) and the maturation stage of 
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melanosomes in the RPE of wild-type and Oa1 mutant mice at different 
developmental and postnatal stages. 
At embryonic day E15.5, newborn P0, and later postnatal stages P7 and 3 
months, the melanosome population in wild-type RPE comprised mostly 
mature stage IV melanosomes. However, a sizable fraction of the 
melanosomes was still at stage II at E15.5 (31%) and at stage III at P0 (14%). 
The total number of melanosomes increased progressively and reached a 
plateau at P7 (Table 1). 
The changes in the total number of melanosomes reflected almost exclusively 
the modifications in the stage-IV population, probably due to the relative 
paucity of stages II and III at P0, P7, and 3 months. 
In Oa1 KO RPE we found that the melanosome population, similar to wild-
type RPE, comprises mostly stage IV melanosomes (Table 1), which included 
also macromelanosomes at P0, P7 and 3 months.  
                                 
 
Table 1. Number of melanosomes in the RPE of wild type and Oa1-/- mice at the different 
developmental stages (the total area of the cell analyzed was determined by the point-intersection 
method and expressed in square micrometers (Rabouille et al. 1999)). 
 
Similar to phenotype described in patients, only a fraction (20%) of 
melanosomes was enlarged (>1.5% µm) (Table 2). 
When compared to wild type, Oa1 KO RPE shows a significant reduction of 
the number of melanosomes, that begins during development (25% of 
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reduction at E15.5) and continues after birth (40% at P0, 50% at P7 and 57% 
at 3 months). 
This reduction was mostly attributable to the stage IV population at P0, P7 
and 3 months, whereas at E15.5 it was due to changes in immature stage II 
melanosomes. 
We didn’t detect autophagosomes suggesting that the reduction of the 
melanosome number was probably due to a reduced rate of organelle 
biogenesis, rather then degradation of already formed organelles. 
 
3.2 Effect of Oa1-/-, Tyr c-2J, and Matpuw mutations on each other and 
cellular distribution 
To define at which stage of melanosomes maturation Oa1 act, we generated 
double-mutant mice of Oa1 with two other albinism mouse models, Tyr 
(OCA1) and Matp (OCA4) in which melanosomes are unable to undergo full 
maturation. 
In Tyr c-2J mice melanin is not synthesized and melanosomes stop their 
maturation at stage II (Costin et al.2003) (Figure 13), in Matpuw mice, the 
mutation causes a block of maturation at stage III (Sweet et al.1998) (Figure 
5). 
Before generating double-mutant mice we have verified that each mutation 
didn’t have an effect on the others. Therefore we have analyzed expression 
and distribution of Oa1 protein in Tyr c-2J and Matpuw mutants. 
To this end, we generated primary cultures of pigment cells dissected from 
wild type, Oa1-/-, Tyr c-2J and Matpuw neonatal eyes. These cultures contained 
both RPE and choroidal melanocytes, as defined by immunodetection of 
pigment cell markers (i.e.Tyr, Tyrp1, and DCT) (Figure 10). 
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Figure 10. Immunofluorescence analysis of melanosomal protein (Tyrosinase, tyrp-1, DCT) 
distribution in pigmented cells dissociated from neonatal Oa1-/-, Tyrc-2J , Matpuw and mutants 
eyes. (A,E,I,M) Micrographs of cell derived from wild-type; (B,F,J,N) from Oa1-/-; (C,G,K,O) 
from Tyrc-2J and (D,H,L,P) from Matpuw mice. (A,B,C,D) Bright-field phase images of the cells in 
(E),(F),(G) and (H), respectively.   
 
To discriminate between the two cell populations, we performed 
immunofluorescence analysis using antibodies to Cralbp, a specific marker 
for RPE cells (Nawrot et al., 2004) and confirmed that cells with elliptic big 
pigment granules were RPE cells (Figure 3 inset). 
Labeling with an Oa1 specific antibody shows that Oa1 was normally 
expressed and distributed in Tyr c-2J and Matpuw mutant RPE and choroidal 
melanocytes, whereas no signal was detected in Oa1-/- cells (Figure 11). 
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Figure 11. Oa1 expression and distribution in Tyrc-2J and Matpuw eyes. Pigmented cells 
dissociated from eyes of neonatal wild-type (wt), were stained with an anti-Oa1 antibody. The 
identity of RPE cells was assessed by staining with anti-Cralbp antibody (inset), which does not 
label choroidal pigmented cells (arrow). Top: interferential reflection micrographs of a typical RPE 
(left) and choroid (right) cell. Bottom: immunofluorescence detection of Oa1 in wild type, Oa1-/-, 
and choroidal cells. Expression of Oa1 in Tyrc-2J and Matpuw RPE and choroidal cells was similar to 
wild type, whereas Oa1 could not be detected, as expected, in Oa1-/- RPE and choroid  
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We then analyzed expression of Tyr and Matp mRNA in Oa1 mutant eyes at 
birth by quantitative real-time PCR. Tyr and Matp expression was not 
impaired in the Oa1-/- genotype compared with the wild type (Figure 12).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12.   Tyrosinase and Matp expression in Oa1 mutant eyes. (A) Real-time quantitative RT-
PCR of Tyr in neonatal (P0), 7 days after birth (P7) and 3 months wild-type (wt, red) and Oa1-/-
(Oa1 mut, blue) eyes. Y-Axis: 2(-dCt) value represents differences between the mean Ct (cycle 
threshold) values of tested genes and those of reference gene. (B) Real-time quantitative RT-PCR 
of Matp in neonatal (P0), 7 days after birth (P7) and 3 months wild-type (wt, red) and Oa1-/-(Oa1 
mut, blue) eyes. 
 
 
Moreover, we have analyzed by immunofluorescence Tyr distribution in RPE 
and choroidal melanocyte primary cultures derived from Oa1-/- neonatal eyes. 
P7 3 months P0 
Tyrosinase expression in Oa1-/- eyes 
P7 3 months P0 
Matp expression in Oa1-/- eyes 
A 
B 
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Also in this case we found no significant differences of Tyr localization as 
compared to wt (Figure 10A, 10B, 10E, 10F), showing that Oa1 loss of 
function does not interfere with the distribution of Tyr. 
Therefore, the absence of Oa1 does not influence the expression of tyr and 
Matp. Altogether, these results suggest that Oa1, Tyr and Matp do not 
reciprocally influence each other expression and subcellular distribution. 
 
3.3 Effect of Oa1 on the rate of melanosome biogenesis and organelle size. 
We generated Oa1-/-; Tyr c-2J/Tyr c-2J double mutant mice and analyzed the 
melanosome phenotype in RPE at P7.  We chose this stage because at this 
time point both the reduced number of melanosomes and the giant 
melanosome phenotype are easily detectable in Oa1-null mice. At P7, no 
melanin was deposited in the melanosomes of Tyr c-2J/Tyr c-2J single mutant or 
Oa1-/-; Tyr c-2J/Tyr c-2J double mutant RPE, and melanosomes stopped their 
maturation at stage II (Figure 13).  
The number of stage II melanosomes was reduced in the Oa1-/-; Tyr c-2J/Tyr c-
2J double mutant compared with the Tyr c-2j/Tyr c-2j single mutant RPE (Table 
3). 
We then evaluated whether the size of melanosomes was affected by the 
combination of the two mutations. To this purpose, we compared the diameter 
at P7 of the most mature stages in each genotype (stage II in Tyr c-2J/Tyr c-2J 
and Oa1-/-; Tyr c-2J/Tyr c-2J and stage IV in Oa1-/-).  
Stage II melanosomes had an average diameter of 0.56 µm in Tyr c-2j/Tyr c-2j 
single mutant RPE and 0.67 µm in the double mutant RPE (Table 2). These 
values were similar to those obtained from wild type stage IV melanosomes 
(0.51 µm), but smaller compared with Oa1-/- macromelanosomes (0.9 µm). 
The reduced number of stage-II melanosomes in double mutant RPE 
demonstrates that Oa1 contributes to the rate of melanosome maturation at 
early stages and independently of melanin synthesis.  
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However, we could not define yet whether melanin synthesis and/or 
melanosome maturation are necessary for the regulation of melanosomal size 
by Oa1. 
 
                      
                        
  
Figure 13. Ultrastructural analysis of RPE melanosomes in different genotypes. (A) 
Micrographs of RPE cells from wild type and Oa1-/- mice at P7. Photographs are at the 
same magnification and show the difference in size of the melanosomes in the two 
animals. Bar:  2.5µm. (B) Micrographs of RPE melanosomes from Tyrc-2J/Tyrc-2J and Oa1-
/-; Tyrc-2J/Tyrc-2J and Matpuw/Matpuw and Oa1-/-; Matpuw/Matpuw mutant mice. Arrows: 
representative stage-II melanosomes. Different stages of melanosomes were found in RPE 
of Matpuw/Matpuw single and Oa1-/-; Matpuw/Matpuw double-mutant mice. Arrowheads: 
stage-III melanosomes. Bar:  0.47 µm. 
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Table 2. Size distribution of melanosomes in the RPE of different genotypes 
 
  Diameter  
  
<1 µm 
 
1-1.5 µm 
 
>1.5 µm 
 
Mean diameter 
(µm) 
Stage IV     
   Wild-type     
         P7     
             % 90 10 0 0.51 
             n 106 11 0  
         3 months     
             % 92 8 0 0.61 
             n 98 9 0  
     Oa1-/-     
          P7     
              % 63 14 23 0.90 
              n 30 7 11  
          3 months     
              % 44 40 16 1.00 
              n 21 19 8  
Stage II     
Tyrc-2J/Tyrc-2J     
           P7     
               % 100 0 0 0.56 
               n 118 0 0  
Oa1-/-;Tyrc-2J/Tyrc-2J     
           P7     
               % 95 5 0 0.67 
               n 41 2 0  
Stage III     
Matpuw/Matpuw     
           3 months     
                % 87 13 0 0.54 
                n 14 2 0  
Oa1-/-;Matpuw/Matpuw     
           3 months     
                 % 97 3 0 0.56 
                 n 40 1 0  
     
 
Data report the number (n) and the percentage (%) of melanosomes counted in each condition and falling  
in each of the three ranges of diameter shown. 
 
Table 3. Number of melanosomes in RPE of Tyrc-2J/Tyrc-2Jand Oa1-/-;Tyrc-2J/Tyrc-2J 
 mutant mice, and Matpuw/Matpuw and Oa1-/-;Matpuw/Matpuw mutant mice.  
 
  Stage  
  
II 
 
III 
 
IV 
 
      Area 
(µm2) 
Stage IV     
     
Tyrc-2J/Tyrc-2J     
         P7 97 0 0 355 
Oa1-/-;Tyrc-2J/Tyrc-2J     
         P7 62 0 0 355 
Matpuw/Matpuw     
         3 months 31 20 0 186 
Oa1-/-;Matpuw/Matpuw     
         3 months 17 50 0 186 
     
 
The total area of the cell analyzed (area) was determined by the point-intersection 
method and expressed in square micrometers. 
  35 
 
3.4 Effect of Oa1 in melanosome maturation 
To address whether melanin deposition and/or melanosome maturation are 
involved in the macromelanosome phenotype, we analyzed the RPE in P7 and 
3 month old Oa1-/-;Matpuw/Matpuw double-mutant mice. In fact Matpuw/Matpuw 
adult RPE display smaller but pigmented melanosomes (Sweet et al.1998).  
At P7 we did not detect any melanosome in both single and double mutant 
mice. At 3 months of age, in both genotypes RPE melanosomes did not 
proceed beyond stage III (Figure 13).   
The number of stage II melanosomes was reduced in the Oa1-/-
;Matpuw/Matpuw double mutant compared with the Matpuw/Matpuw single 
mutant RPE (Table 3). 
By morphometry, we measured similar diameters in the Matpuw/Matpuw single 
mutant (0.54 µm) and in the Oa1-/-;Matpuw/Matpuw double mutant (0.56 µm) 
RPE (Table 2). 
Altogether these results suggested that Oa1 exerts a size control function only 
on fully developed stage IV melanosomes, independent of melanin synthesis. 
Therefore, melanosome maturation and not melanin deposition has a direct 
influence on the formation of macromelanosomes. 
Our findings indicate that Oa1 is involved in the regulation of melanosome 
maturation at two steps. Acting at early maturation stages, Oa1 controls the 
abundance of melanosomes in RPE cells. At later stages, Oa1 has a function 
in the maintenance of a correct melanosomal size.  
 
   3.5 OA1 protein localization in pigmented cells in vitro 
Given the limitation to further explore the function of Oa1 in RPE cells using 
genetic approaches we decided to go further onto the role of Oa1 in 
melanosome maturation in pigmented cells in vitro taking advantage of cell 
biology methods.  
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In contrast to canonical GPCRs, OA1 does not translocate to the plasma 
membrane, but is exclusively detectable on the membrane of intracellular 
organelles in pigmented cells (Schiaffino et al. 1999). Moreover, some 
controversy exists on the precise subcellular localization of the protein. Our 
aim was to identify the subcellular compartments “sensitive” to Oa1 activity 
analyzing the intracellular localization of OA1 in HeLa cells and in human 
and mouse melanocytes.  
To this purpose we generated two different OA1 tagged constructs 
(humanOA1-EGFP and humanOA1-Flag) in which the full length OA1 
cDNA was cloned at the N-terminal of the tag sequences in the pEGFPN1 and 
pcDNA3-Flag vectors. 
First we tested their expression in HeLa cells, in which OA1 normally is not 
expressed. Given the high efficiency of transfection in HeLa (85%), we used 
this cell line to find the best condition to express this integral membrane 
protein spanning the membrane 7 times and to validate the constructs by IF 
and western blot analysis. Immunofluorescence analysis on HeLa transfected 
cells with both constructs revealed an intracellular localization of OA1 in 
punctate structures (Figure 14A, 14B).  
Interestingly, only cells expressing OA1-Flag shows the presence of all the 
maturation forms of OA1 (48kDa unglycosilated and 60kDa glycosilated 
forms) as detected by Western blot analysis of HeLa transfected cells  (Figure 
14D). In fact, the OA1-EGFP fusion protein (48kD of OA1+27kDa of EGFP) 
lacks the glycosilated mature form of 87kDa (60kDa+27kDa) and shows only 
the unglycosilated doublet of 75kDa (48kDa+27kDa), suggesting that the 
protein doesn’t mature properly (Figure 14C). 
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Figure 14. Localization of OA1 in late endosome (MVBs) and lysosome in HeLa 
transfected cells. (A, B) Immunofluorescence analysis of OA1 localization in HeLa 
transfected cells, using OA1-EGFP and OA1-Flag tagged constructs. (C, D) Western 
blotting analysis of HeLa cells transfected with the two OA1-tagged constructs shows the 
presence of all the maturation forms of OA1 only in the OA1-flag cells 48kDa, 60kDa and 
90 kDa). (E, F) Ultrathin cryosections from OA1-EGFP and OA1-flag transfected Hela 
cells were double immunogold labeled with anti-EGFP or anti-flag (10 nm gold) and anti-
CD63 (15 nm gold), a tetraspanin protein present on the MVBs. The bulk of OA1 localizes 
to late endosomes (MVBs) and lysosomes. Note the distribution of OA1-flag in the 
limiting membrane and in the internal vesicles of MVBs, whereas the OA1-EGFP, that is 
not fully mature (see western blotting) is mostly retained in the limiting membrane.   
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To investigate the nature of the intracellular compartments to which OA1 
localizes we have carried immunocytochemistry at EM level.  
Ultrathin cryosections from OA1-EGFP and OA1-Flag transfected HeLa cells 
were double immunogold labeled with antiEGFP or antiFlag (10nm gold) and 
antiCD63 (15 nm gold), a tetraspanin protein present in late endocytic MVBs, 
or Lamp1(15 nm gold), a transmembrane protein localized in MVBs and 
lysosomes. As shown by the OA1 co-localization with CD63 and Lamp1 the 
bulk of OA1 localizes to the multivesicular-multilamellar late endosomes 
(MVBs) and lysosomes. Interestingly, OA1-EGFP that is not fully mature (as 
shown in WB) is mostly retained in the limiting membrane of MVBs, whereas 
the OA1-Flag is distributed also in the internal vesicles, like CD63 (Figures 
14E, 14F) and Lamp1 (data not shown). 
The incomplete maturation of OA1-EGFP protein may explain why previous 
studies using GFP tagged OA1 reported OA1 protein localization only in late 
endosomes and not in melanosomes (Samaraweera et al., 2001). For this 
reason we have used only the OA1-flag construct to study OA1 localization in 
pigmented cells.  
IF experiments performed in melanocytic cell lines revealed that OA1 
localizes in pigmented melanosomes but also in not pigmented compartments 
(Figures 15A-C). Indeed, OA1 almost totally overlaps with Lamp1, and 
partially overlaps with Tyrp-1, a melanosomal enzyme involved in melanin 
synthesis and localized mostly to mature melanosomes. In contrast we did not 
observed overlay with the premelanosomal protein Pmel17, a major 
component of the stage II premelanosomes (Figures 15D-J). 
Further on, we have analyzed the OA1 subcellular distribution at 
ultrastructural level by Electron Microscopy in human melanoma cells 
(MNT1) and mouse melanocytes (melan-A).  
Immunogold labeling on ultrathin cryosections of transfected MNT1 and 
melan-A cells revealed that OA1 is present in mature melanosomes (stage III 
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and IV). In those, OA1 was often observed at the limiting membrane but also 
in small intraluminal vesicles that are labeled by Tyrp-1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. OA1 subcellular distribution in melanocytic pigmented cells. Melanocytes 
were transiently transfected with OA1-flag and subsequently analyzed by 
immunofluorescence. (A, B) Oa1 (green) localizes in pigmented melanosomes but also in 
not pigmented compartments (A, B, C). OA1 (green) almost totally overlaps with Lamp-1 
(red) (D, E, F), only partially co-localizes with Tyrp-1 (red) (G, I) but not with Pmel17 
(red) (H, J).  
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Interestingly, OA1 was also present in membrane vesicles “endosome-like” 
that are electron lucent and are very often close to melanosomes in both 
MNT1 and melan-A cells (Figure 16). These vesicles contained also Tyrp-1. 
Despite the observations by IF that OA1 partially overlaps with Tyrp1, the 
detailed analysis at the ultrastructural level demonstrates that at “steady state” 
OA1 localizes to mature melanosomes and to closely apposed vesicles, both 
labeled also for Tyrp-1, suggesting an involvement of OA1 in controlling at 
some step the biosynthetic or endocytic trafficking of Tyrp-1+ vesicles. 
 
 
 
Figure 16. OA1-Flag localizes to melanosomes and vesicles. Ultrathin cryosections of 
human (MNT1) and mouse (melanA) melanocytic cells transfected with OA1-flag were 
immunogold labeled with anti-Flag (15 nm gold) and anti-tyrp-1 (10 nm gold) antibodies. 
Labelling for OA1 is indicated by arrows.  
 
 
  41 
3.6 In vitro analysis of the melanosomal phenotype in Oa1 null 
melanocytes  
In order to understand the trafficking steps affected by the absence of Oa1 
protein, we performed a detailed analysis of the macromelanosome phenotype 
of Oa1 null skin murine melanocytes. By light microscopy we observed that 
the Oa1 KO melanocytes cultured in vitro contain less melanosomes of 
different sizes mixed with giant macromelanosome, as we have previously 
seen in the RPE in vivo. Of note, the giant melanosomes were retained in 
perinuclear region and appear to be less motile than the normal melanosomes 
(Figure 10B). It’s possible that these macromelanosomes are not properly 
mature organelle and/or their composition in melanin proteins is altered, 
leading to a failure in the recruitment of effector proteins necessary to 
delivery them to periphery. 
We performed IF experiments to verify the distribution of melanosomal 
proteins involved in melanin synthesis (Tyrosinase, Tyrp-1, DCT) or 
constituents of the striations of premelanosomes (Pmel17) and also of one late 
endosome/lysosome protein (Lamp1). We didn’t find evident differences in 
their distribution as compared to wild type melanocytes (Figure 17).  
We then performed ultrastructural analysis by Electron Microscopy in these 
cells and we found the presence of abnormal melanosomes with a 
heterogeneous content. Sometimes they appeared as a mixture of immature 
striated melanosomes with an electron-dense pigmented content (Figure 18C-
18F).  
The immunocytochemistry experiments performed at EM level to localize 
melanosomal protein in Oa1 KO melanocytes did not allow identifying a clear 
defect in trafficking of melanosomal proteins. 
However, we found that the fibrillar structures apposed to these abnormal 
melanosomes were mostly labeled for Pmel17, a major component of the 
typical stage II striations (Figure 18G). 
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Figure 17: Expression and distribution of melanosomal proteins in Oa1-/- (melan-o) skin 
melanocytes. We analyzed the localization of melanosomal (tyrosinase, tyrp-1, pmel17) and 
lysosomial (lamp-1) proteins in Oa1-/- (melan-O) (B, D, F, K) compared with wild-type 
melanocytes (melan-a) (A, C, E, G). A and B are interferential reflection micrographs of wild-type 
(melan-a) and Oa1-/- (melan-O) melanocytes shown in C and D; immunofluorescence detection of 
Tyrosinase (green)/Pmel17 (red) (C,D); Tyrosinase (green)/ Tyrp-1(red) (E,F); Tyrp-1(red)/Lamp-
1(green)(G,K). All these proteins did not display evident differences in their expression and 
distribution when compared in the two genotypes. Note the astrocyte-like shape of the majority of 
Oa1-/- melanocytes (K). 
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Figure 18: Oa1-/- mouse skin melanocytes (melan-o) show a reduction of the number of 
melanosomes and the presence of macromelanosomes as observed by light (B) and elecron 
microscopy (D). wild-type melanocytes are shown in A, C, E. Red arrowhead: macromelanosome. 
A subset of melanosomes in Oa1-/- displays an irregular shape and a not homogeneous melanin 
content. They appear as a mixture of immature striated melanosomes (arrows) with an electron 
dense pigment content (F). The striation at the periphery is Pmel17 positive (5 nm gold), as 
indicated by the arrows in (G).  
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The Oa1 KO phenotype analysis in skin melanocytes suggests that the 
absence of Oa1 affects melanosome maturation in vitro, but did not allow a 
clearly understanding of the trafficking step that is affected by loss of Oa1. 
In fact, in these cells we were observing an “end-point” situation, with 
primarily mature organelles and it may represent the consequence of many 
sequential events. We are therefore interested in developing a method that 
allows us to looking at the progression of the events that really leads to the 
macromelanosome phenotype. 
 
3.7 OA1 inactivation in human melanoma MNT1 cells in vitro 
In order to analyze the progression of the events that lead to the 
macromelanosome phenotype we performed RNA interference of OA1 using 
siRNA in MNT1 cells in vitro and then analyzed the phenotype by performing 
immunocytochemistry at ultrastructural level. This methodology will allow 
following melanosomal maturation right after the loss of OA1 activity and, 
therefore, unraveling the sequential steps leading to the macromelanosome. 
We have tested 3 different sequences of oligonucleotides targeting 3 different 
regions of the human OA1 mRNA. As a control we have used a double strand 
siRNA targeting a transcript expressed exclusively in plants. After 1 week of 
inactivation we performed qPCR to verify the reduction of mRNA levels on 
interfered cells. Among the 3 sequences one was confirmed to be very 
efficient in reducing the expression of OA1 mRNA levels (about 85-90%) 
(Figure 19A). 
 We have also tested the ability of this sequence to downregulate OA1 
protein. Because an antibody anti-human OA1 was not available, we 
performed this analysis on OA1-EGFP transfected MNT1 cells and we found 
that the OA1-EGFP protein was strongly reduced in the MNT1 interfered 
cells in vitro as shown by western blot (Figure 19B).  
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After 1 week of inactivation melanin assay shows that the melanin content in 
siOA1 MNT1 cells was reduced as much as 50% compared to cells treated 
with the control siRNA (Figure 19C). Ultrastructural analysis on siOA1 
MNT1 cells showed a reduction of the total number of melanosomes in siOA1 
MNT1 cells as compared with the control cells (Figure 19E, 19F).  
These observations indicated that OA1 interference in MNT1 cells leads to a 
significant reduction of pigmentation and of the number of melanosomes, 
reproducing the phenotype characterized in the Oa1 KO mouse and in 
patients. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19 (A, B): 1 week interference (siRNA) of OA1 leads to a significant reduction of its 
mRNA and protein levels in MNT1 cells as quantified by qPCR (A) and western blotting (B), 
respectively. Quantitative PCR was performed on siOA1 MNT1 to detect the mRNA levels of 
endogenous OA1. Western blotting was performed on MNT1 cells transfected with OA1-EGFP 
and then interfered using siOA1 oligos. After 1 week we detected the protein levels of OA1-EGFP. 
We used as control MNT1 cells transfected with pEGFP vector and then interfered with a non-
targeting sequence. 
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Figure 19 (C, D, E, F): Inactivation of OA1 in MNT1 cells by siRNA leads to a decrease in 
melanin content as analyzed by quantification of melanin (C) and to a decrease number of 
melanosomes as analyzed by Electron Microscopy (E, F). (D): siOA1 cells display abnormal 
pigmented structures (arrow) that are bigger then melanosomes in wild type. Bar: 250 nm 
 
 
We did not detect macromelanosomes (certainly, the macromelanosome 
phenotype requires more then 1 week to develop in vitro), but, interestingly, 
we have observed an accumulation of Tyrp-1 in large vacuolar compartments, 
often very close or even in continuity with the melanin containing membrane 
structures. Although the melanin content was reduced in siOA1 MNT1 cells, 
Western blot experiments performed in these cells display an increase in the 
amount of Tyrp-1, suggesting a defect in its trafficking and/or degradation 
(Figure 20).  
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Figure 20. Accumulation of Tyrp-1 in large vacuolar compartments in siOA1 MNT1 interfered 
cells. Top: After 1 week of OA1 inactivation macromelansomes are not detectable, but there is an 
accumulation of large vacuolar structures in siOA1 MNT1 cells (B) compared with the control cells 
(A).  These vacuoles contain a big amount Tyrp-1, a melanosome enzyme normally present in 
mature melanosomes (stage III, IV), and are very close to the melanin containing compartments 
(arrows). Western blotting analysis confirmed the up-regulation of Tyrp-1 protein in siOA1 MNT1 
cells (D). Note the presence of pigmented melanosomes with increased membrane and Tyrp-1 
quantity (C). Bottom: typical field of siOA1 MNT1 cells displaying Tyrp-1 positive vacuoles 
accumulation. 
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To better characterize Tyrp-1 labelled vacuoles and in particular their possible 
endosomal nature we allowed the siMNT1 and control cells to internalize 
transferrin (Tf-biotin) for 45 min (a kinetics necessary to load the early 
endosomal system). The Tyrp-1 vacuoles in siOA1 MNT cells did not appear 
to be easily accessed by transferrin when compared to the control cells 
(Figure 21A-D). These findings suggested that these compartments are not 
part of the early endocytic system and they may represent a subdomain not 
accessible to the transferrin receptor. 
Of note, these vacuoles contain Pmel17, a component of immature 
melanosomes (Figure 21E). Surprisingly, Tyrp-1/Pmel17 containing vacuoles 
accumulated also Lamp1, a late endosomal and lysosomal protein (figure 22). 
These studies revealed an increased amount of Lamp1 also at the membrane 
of the pigmented structures. In some cases the vacuolar compartment is 
labeled also for TGN46, a protein that localizes mostly to TGN (Figure 21F). 
On the whole, the ultrastructural analysis of the OA1 inactivated cells showed 
that in the absence of OA1 the decrease of the number of melanosomes is 
accompanied by an increase of enlarged compartments containing 
melanosomal proteins (Tyrp-1 and Pmel17) but also other proteins that are not 
normally present in high amounts in pigmented structures (Lamp1 and 
TGN46). Further studies are needed to further characterize this intracellular 
compartment and to understand how the absence of OA1 leads to the 
reduction of melanosome number and the giant melanosome phenotype. 
However, these results all together indicate a function for OA1 in the 
maintenance of melanosome identity and composition. Moreover, we 
speculate that OA1 signaling activity may control fusion or fission events 
between an intracellular compartment and melanosomes during their 
maturation.  
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Figure 21: (A,B,C,D): Tyrp-1 containing vacuoles are not easily accessed by transferrin. 
Transferrin (early-recycling endosome tracer) conjugated with biotin was internalized for 45 min in 
siOA1 MNT1 (B,D) and control (A,C) cells. Internalization was controlled by immunofluorescence 
(A,B) and electron microscopy (C,D) by using anti-biotin antibody. Transferrin (Tf-biot 15 nm) 
was present in early endosomes (arrows) in both siOA1 and control cells, but preferentially not in 
the large vacuoles Tyrp-1 (10 nm) positive (arrowhead in D).  (E,F): Tyrp-1 vacuolar 
compartments contain Pmel17 (5 nm; blue arrow in E), a component of immature melanosomes, 
and in some cases, TGN46 (15 nm; red arrow in F) , a TGN protein. Tyrp-1 (10 nm). 
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Figure 22: Tyrp-1 positive vacuoles contain also Lamp1, a late endosome-lysosome protein. Note 
the increased amount of Lamp1 at the membrane of the melanosomes (arrows in B) in siOA1 
MNT1 cells, compared to the normal levels in the control MNT1, in which Lamp1 is 
predominantly present in lysosome (arrow in A). 
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3.8 Microarray expression analysis on Oa1-/- embryonic RPE to elucidate 
OA1 downstream pathway 
In order to identify factors affected by the Oa1 loss of function we compared 
the transcriptome of wild type and Oa1 null pigment cells. As previously 
described, Oa1 null skin melanocyte are not a good system to identify genes 
involved in the sequential events leading to the OA1 phenotype. For this 
reason we chose to perform a microarray analysis on embryonic tissue. 
Melanocytes cannot be easily purified from embryos while RPE is more 
easily accessible due to its anatomical location. We therefore collected murine 
embryonic eyes from E14.5 wt and Oa1 mutant mice, derived from the same 
litter to limit differences derived from gestation, to be compared by 
microarray analysis (Affimetrix mouse whole genome chip). Microarray 
experiments have been repeated with three biological samples to allow 
statistical analysis. We chose E14.5 developmental age because at this stage 
RPE is pigmented and the number of melanosomes is already reduced in the 
Oa1 null mouse. The gene with the highest difference was OA1 (GPR143) 
itself, confirming the quality of this analysis.  
Among the several genes either up or down regulated in Oa1 null eyes (Table 
4), genes involved in vesicle trafficking caught our attention. The most 
interesting genes among these were Trappc4 (Ethell et al. 2000, Kim et al. 
2006, Miller et al, 2007), Cog-4 (Ungar et al. 2002, 2006) and Syntaxin-5a 
(Barrowman et al., 2000; Tai et al. 2004), all involved in vesicle transport in 
the biosynthetic pathway (ER-Golgi-TGN).  In fact the reduced number of 
melanosomes and their increased size in Oa1 null mice may be related to 
defective trafficking from the biosynthetic pathway to the melanosomes. 
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Table 4. Genes up or down regulated in Oa1 null (Oa1-/-) eyes. 
 
genes description Oa1-/- 
Ttn (Titin) Structural constituent of cytoskeleton _ 
Kifc1 (Kinesin family member C1) Microtubule motor  _ 
Gpr126 (GPCR126) G protein coupled receptor _ 
Synpo2I (Synaptopodin-2-like) Actin binding protein _ 
Cart1 (Cartilagine homoprotein-1) Transcription factor _ 
Trappc4 (Transport protein particle 
subunit 4) 
TRAPP multiproteic complex subunit, ER-Golgi 
vesicles trafficking 
++ 
COG4 (Component of oligomeric golgi 
complex 4) 
COG multiproteic complex subunit, intra-Golgi 
vesicles trafficking 
++ 
Mcoln1 (Mucolipin-1) Cation ion channel in late endosomes and lysosomes + 
Sytx-5a (syntaxin-5a) SNARE protein, ER-Golgi-TGN vesicle transport 
and fusion 
++ 
Golga1 (Golgi autoantigen-1) Golgi apparatus protein + 
Gpaa1 (GPI anchor attachment protein-1) GPI anchor protein + 
Gas5 (Growth arrest specific 5) Non-protein-coding small nucleolar RNA + 
Dolpp1 (Dolichyl pyrophosphate 
phosphatase 1) 
Endoplasmic Reticulum protein + 
Tmem23 (Transmembrane protein 23) Golgi transmembrane protein + 
 
 
In order to confirm the variation of expression of these genes, we performed 
qPCR on the same RNA used for the microarray (Figure 23A), and on wt and 
Oa1-/- embryonic (Figure 23D), neonatal (Figure 23B) and 7 days postnatal 
(Figure 23C) RPE dissected and separated from the neural retina. We 
confirmed the upregulation of these genes in Oa1 mutant embryonic and 
neonatal RPE, but not at P7, when the macromelanosomes were completely 
formed, suggesting that Oa1 regulate these genes before macromelanosome 
formation. Interestingly, when we dissected RPE from neural retina we 
confirmed the specificity of the effect in the pigmented cells because no 
change of expression was detected in mRNA derived from Oa1-/- neural 
retina. 
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In order to understand whether changes in Trappc-4, Cog-4 and Stx5-a could 
be reproduced in vitro we analyzed the expression of these genes after 7 days 
of OA1 inactivation in MNT1 cells in vitro by qPCR and western blot.  As 
expected, we confirmed an upregulation of these genes in the Oa1 defective 
cells and also of the proteins they encode (Figure 23E, 23F). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. Upregulation of ER-Golgi vesicle trafficking genes (Trappc-4, Cog-4 and Syntaxin-5) 
in OA1 mutant eyes and in siOA1 interfered MNT1 cells. (A,B,C,D): Real time quantitative PCR 
shows upregulation of ER-Golgi vesicle trafficking genes (Trappc-4, Cog-4 and Syntaxin-5) in 
OA1 mutant embryonic (E14.5) eyes (A), embryonic (E14.5) dissected RPE (D) and neonatal  (P0) 
(B) eyes compared to wild-type. We did not detect any difference of the expression levels of these 
genes at P7 postnatal day. (E,F): Real time quantitative PCR (E) and Western blotting (F) 
confirmed upregulation of ER-Golgi vesicle trafficking genes also in siOA1 MNT1 after 1 week of 
inactivation in vitro: RNA  (Trappc-4, Cog-4 and Syntaxin-5) and protein (Trappc-4, Sytx-5) 
quantification. 
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Oa1 null skin melanocytes did not show differences in the expression of these 
genes when compared to the wild type melanocytes. Interestingly, they 
displayed an expansion of the ER and the Golgi as showed by the broader 
intracellular distribution of GM130, a coiled coil protein involved in tethering 
of vesicles coming from ER to the cis-Golgi (Moyer et al., 2001; Alvarez et 
al., 2001; Appenzeller-Herzog et al. 2006) and of Rab-1 (Allan et al., 2000; 
Cao et al., 1998; Moyer et al., 2001; Appenzeller-Herzog et al. 2006), a small 
GTP-ase involved in the events that precede the fusion of this vesicles with 
the cis-Golgi surface (Figure 24). We should point out that also OA1 
inactivated melanocytic cells displayed the same phenotype. Our preliminary 
data showed a putative link between OA1 defect and proteins that regulate 
biosynthetic trafficking during melanosome biogenesis.  
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Figure 24. Subcellular distribution of proteins involved in ER-Golgi vesicle transport in siOA1 
MNT1 cells (A,B) and mouse Oa1-/- melanocytes (C,D,E,F).   Immunofluorescence detection of 
Rab 1 (green) and Trappc4 (red) proteins displays an expansion (arrow) of the Rab1 compartment 
in siOA1 MNT1 cells (B) compared with the control cells (A). The expansion of Rab1 
compartment, (C,D) as well as of GM130 (E,F) , was present also in Oa1-/- (melan-o) compared to 
wt (melan-a) melanocytes..  
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                                  4. FUTURE PRESPECTIVES 
 
Further studies are needed to better understand OA1 function in melanosome 
biogenesis. We will focus on three different aspects: 
1) we are planning to go deeper in the analysis of the phenotype of the siOA1 
melanocytic cells in vitro i) measuring the pH in the intracellular 
compartments including melanosomes, ii) analysing the activity of tyrosinase, 
iii) performing BSA-gold internalization). Another aspect that we are going to 
investigate is the link between trafficking and Oa1 downstream signalling 
pathways. Our first aim is to unravel Oa1 signaling mechanism (via cAMP 
and/or Calcium increase) by measuring the intracellular levels of cAMP and 
Calcium in Oa1 inactivated cells.  
2) we are going to better characterize the genetic interaction between OA1 
and the newly identified genes involved in vesicle trafficking. We are 
preparing constructs to either downregulate Trappc-4, Cog-4 and Stx5-a by 
RNAi or upregulate them by transfection. These approaches are aimed to 
define the involvement of these proteins in melanosome biogenesis. We 
expect that if trafficking proteins are actively acting in melanosome 
biogenesis a melanosomal phenotype similar to the Oa1 null phenotype will 
be detectable in the over-expression experiments. 
We are also planning to knock-down these proteins in Oa1 mutant murine 
skin melanocytes in vitro to define whether their up-regulation detected in 
Oa1 null cells is causative of the Oa1 phenotype. For all these experiments we 
will perform ultrastructural analysis at the EM level. 
These studies will be a first step towards a characterization of the Oa1 
signaling pathway, and they will open new perspectives to design specific 
therapeutic approaches for this disease. 
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        5. DISCUSSION 
 
Two main classes of albinism that affect pigmentation in the eye have been 
described: oculocutaneous albinism (OCA) and ocular albinism (OA). In 
OCA hypopigmentation is caused by inadequate melanization of an 
apparently normal number of melanosomes, whereas OA1 was suggested to 
result from reduced number of melanosomes (O’Donnell et al., 1976). 
Patients with OA1 have a severe reduction of visual acuity, horizontal and 
rotatory nistagmus, photophobia, and lack of stereoscopic vision due to 
misrouting of the optic tract. A peculiar melanosome phenotype in these 
patients is characterized by the presence of pigmented melanosomes with a 
giant size (Wong et al., 1983; O’Donnell et al., 1976), suggesting that the 
absence of OA1 could interfere with the normal melanosome biogenesis. 
However, we still lack a comprehensive view of how this phenotype is 
acquired and how it relates to the hypopigmentation observed in the RPE.  
The focus of the studies reported in this thesis have been to address the 
following questions: i) how the presence of pigmented melanosomes 
reconciled with the observed albino phenotype in the RPE; ii) at which 
stage(s) of melanosome maturation OA1 exerted its function; iii) whether an 
impaired control of melanin synthesis and/or of rate of melanosome 
biogenesis was involved in giant melanosome formation. The first 2 questions 
were addressed during the first two years of PhD studies during which we 
defined the differences between OA (albinism isolated to the eye) and OCA. 
For these studies we took advantage of murine models of OCA and OA1. We 
focused our attention on two aspects of melanogenesis in the RPE: rate of 
melanosome formation and size control. Through a deep ultrastructural 
analysis of melanosomes in Oa1 mutant RPE we found that these events are 
both affected by lack of Oa1 activity. 
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We first characterized Oa1 interaction with Tyr in Oa1 mutant mice and 
showed that there is no impairment of Tyr activity and expression. This aspect 
of the phenotype differentiates Oa1 from other albino mice in which melanin 
production is affected (LaVail et al., 1978). However, the number of mature 
melanosomes in Oa1 mutant eyes was reduced by 50% in the RPE after birth 
explaining the depigmented ocular fundus. This reduction was in the number 
of stage IV melanosomes. It is possible that the effect on others melanosomal 
stages is masked by the lower number of stage-II and stage-III melanosomes. 
In fact, a reduction in the number of stage-II melanosomes was detected in 
mutants when melanosome maturation is stopped previous to stage IV (Oa1-/-
;Tyrc-2J/Tyrc-2J and Oa1-/-;Matpuw/Matpuw double mutants) and at embryonic 
stages. These results demonstrate, for the first time, that the reduced 
pigmentation of the RPE observed in patients with ocular albinism type 1 is 
caused by reduced number of pigmented melanosomes.  
Another relevant aspect of Oa1 function highlighted by our studies in the Oa1 
mutant mouse is the size control activity of Oa1 specifically on stage-IV 
melanosomes. This conclusion is based on the absence of melanosome 
enlargement in the RPE of Oa1-/-;Tyrc-2J/Tyrc-2J and Oa1-/-;Matpuw/Matpuw 
double mutant mice which lack stage-IV melanosomes and display either 
stage-II or stage-III, respectively. Therefore, in the absence of fully mature 
melanosomes Oa1 is dispensable for size control.  
Whereas the Oa1 size control activity is specific for the most mature 
melanosomes, an additional Oa1 function appears to be exerted at earlier 
stages of maturation. In particular, in Oa1-/- single and double mutants, the 
number of stage-II was reduced at the earliest stages of maturation analyzed: 
E15.5 for Oa1-/-, and P7 or 3-month postnatal stages for Oa1-/-;Tyrc-2J/Tyrc-2J 
and Oa1-/-;Matpuw/Matpuw double mutants.  In contrast stage-III were more 
abundant in Oa1-/-;Matpuw/Matpuw double mutants compared with 
Matpuw/Matpuw single mutant mice. This suggests that Oa1 may at the same 
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time control the maturation rate of melanosomes and inhibit the overgrowth 
of the most mature ones. We cannot exclude, however, that the phenotype 
observed in double mutant mice could also be due to a specific interaction 
between the two genes. Although our findings indicated that Oa1 regulates 
melanosome maturation and size, by using the double mutant approach we 
have not defined yet the mechanisms by which Oa1 may perform its double 
function. Heterotrimeric G-proteins associated with intracellular organelles 
have been described to participate in various steps of secretion and vesicular 
fusion and organelle maturation, even though no specific intracellular GPCR 
has yet been described for these functions. One hypothesis is that OA1 may 
act as a melanosome GPCR, either constitutively active, or activated by 
melanin or by a product of melanin synthesis, that control membrane delivery 
to the melanosomes. OA1 represents the first example identified so far of an 
exclusively intracellular GPCR (Schiaffino et al., 1999). Discrepant data have 
been published on OA1 subcellular localization (Schiaffino et al., 1996; 
Samaraweera et al. 2001) leaving an open controversy.  
The studies performed in the last period of my phD, making profit of cell 
biological methods, allowed us to solve this controversy and to better 
understand Oa1 function in melanosome biogenesis elucidating some of the 
trafficking events leading to the two Oa1-/- defects, the reduction of early 
stage melanosomes and the presence of macromelanosomes.  
We addressed the issue of OA1 localization by immunofluorescence and 
immunogold analysis of the OA1 distribution primarily in pigmented cells 
(mouse and human melanocytes) and also in not pigmented cells. This 
strategy made use of OA1-tagged constructs, in particular OA1-flag that 
allowed a complete maturation of the OA1 protein when transfected in 
melanocytes. Of notice is that studies, suggesting OA1 protein localization 
only in late endosomes and not in melanosomes, were performed using a GFP 
tagged OA1 that in our hands did not allow post-translational modifications 
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(Samaraweera et al., 2001). We found that OA1 is similarly distributed along 
both the late endosomal-lysosomal (as shown by the co-localization with 
Lamp-1, a late endosome protein) and the melanosomal compartments in 
melanocytic cells (as shown by the colocalization with Tyrp-1, a melanosome 
specific protein). In particular, electron microscopy showed that OA1 is 
present in the limiting membrane and also in internal vesicles of late stage 
melanosomes, mostly associated with Tyrp-1. Correlation of OA1 expression 
with Tyrp1 suggests that OA1 may be involved in controlling some steps of 
the biosynthetic or endocytic trafficking of this protein at later stages of 
melanosome maturation.  
A detailed analysis of the melanosomal phenotype in mouse Oa1-/- 
melanocytes revealed that macromelanosomes are intermixed with normal 
size melanosomes as also seen in the RPE of mutant mice (Cortese et al., 
2005). Furthermore, macromelanosomes, that are three times bigger than the 
normal melanosomes, were retained in the perinuclear region of melanocytes 
and appeared to be less motile than normal melanosomes. This phenotype 
opens the hypothesis that these giant melanosomes are not properly mature 
organelle and/or their composition in proteins is altered, leading to a failure in 
the recruitment of effectors proteins necessary to delivery them to the 
periphery. EM analysis showed the presence of melanosomes with irregular 
shape and not homogeneous melanin content in Oa1-/- melanocytes. They 
appear as a mixture of immature striated melanosomes, pmel17 positive, with 
a central core similar to pigmented mature melanosomes.  
Many studies using mouse models of other pigmentary disorders (e.g. 
Hermansky Pudlack Syndrome, HSP) have helped to understand the steps 
affected by mutations in the HSP genes in vesicle trafficking controlling 
melanosome biogenesis. The analysis of the phenotype generated by Oa1 loss 
of function in skin melanocytes suggests that the absence of Oa1 affects 
melanosome maturation and their protein composition, but did not allow to 
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clearly understand the trafficking step involved in the generation of the OA1 
defect. In fact, in these cells we were observing an “end-point” situation that 
is the consequence of many events that have produced the Oa1 defect.   
To overcome this limit we chose to follow the morphological and molecular 
events starting as soon as OA1 is inactivated. To this purpose we have 
downregulated OA1 mRNA by siRNA in human MNT1 melanocytic cells. 
This approach has revealed very helpful to follow melanosomal maturation 
right after the loss of OA1 activity and, therefore, unravel the sequential steps 
leading to the formation of macromelanosomes. 
We confirmed that this technique was very efficient in reducing the 
expression of OA1 mRNA and protein as analyzed by real-time RT-PCR and 
western blotting. After 1 week of inactivation of OA1, MNT1 cells did not 
contain the typical macromelanosomes, but they showed a significative 
reduction of melanin content and of the number of melanosomes, as in Oa1-/- 
RPE in vivo. This was the first evidence that siRNA can reproduce the OA1 
phenotype in vitro. The ultrastructural analysis of OA1 inactivated cells 
showed that in the absence of OA1 the reduction in the number of 
melanosomes is accompanied by an increase of enlarged compartments 
containing melanosomal proteins (Tyrp-1 and Pmel17) but also proteins that 
are not normally present in high amounts in pigmented structures (Lamp1 and 
TGN46). These enlarged compartments cannot be labeled by transferring in 
endocytosis experiments, suggesting that they are not part of the early 
endocytic pathway, but they may represent a subdomain not accessible to the 
transferrin receptor. Our studies revealed an increased amount of Lamp1 also 
at the membrane of the pigmented structures. Although further studies are 
needed to better characterize this intracellular compartment and to understand 
how the absence of OA1 leads to the reduction of melanosome number and 
the giant melanosome phenotype, all together our results indicate OA1 may 
be a key factor controlling the maintenance of melanosome identity and 
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composition. In fact in aberrant vesicles forming as a consequence of OA1 
knockdown we detected melanosomal and lysososmal and TGN proteins.  
We can also speculate that OA1 signalling activity may influence fusion or 
fission events between intracellular compartments and melanosomes, but also 
in between different melanosomal stages, during their maturation. This 
hypothesis was forwarded based on the evidence that absence of OA1 caused 
reduction of early stage melanosomes, presence of aberrant pigmented 
structures that appears as a mixture of early stage (stage-II) with pigmented 
late stage (stage-IV) melanosomes.  
Detailed ultrastructural analysis defined morphological alterations that are 
possibly due to vesicle trafficking defects. In order to identify molecules, 
important for these cellular events, that are affected by lack of OA1 we 
undertook a systematic analysis of the transcriptome of Oa1 wild type and 
mutant RPE. We chose to use tissue from the mouse model because we 
wanted to identify factors that are causative of the albino phenotype. RNA 
was purified from murine E14.5 embryonic eyes from wild type and Oa1 
mutant mice. We preferred to use embryonic tissue because at this stage 
melanosomes are already less abundant but macromelanosomes are not 
evident yet suggesting that melanogenesis is still active and molecular defects 
can be revealed. With these samples we probed whole murine genome 
microarrays and identified interesting genes, involved in vesicle trafficking, 
that are upregulated in Oa1 mutant RPE. The most interesting genes among 
them were Trappc-4 (Cai et al. 2005; Sacher et al. 1998, 2001), Cog-4 (Ungar 
et al., 2006) that are two subunits of two large multiprotein complex called 
TRAPP and COG Also Syntaxin-5 (Barrowman et al., 2000; Guihua et al. 
2004), a SNARE protein, was upregulated in Oa1 null eyes. Interestingly, the 
yeast homologue of Syntaxin-5 interacts with one subunit of TRAPP and 
some subunits of COG complexes (Barrowman et al. 2000). These three 
complexes are all involved in vesicle transport during the biosynthetic 
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pathway (ER-Golgi-TGN). Based on several recent evidences the different 
subunits of the tethering complex, like the TRAPP complex, may participate 
in additional events in mammals, playing a role in multiple vesicular transport 
events and performing specific critical function beyond generalized ER-to-
Golgi transport (Ethell et al. 2000) (Cai et al., 2005) (Ungar et al., 2006). We 
wanted to confirm the link between the tethering complex with Oa1 and 
define the time window during which it happens. To this purpose we collected 
RNA from embryonic neonatal and adult murine eyes. These experiments 
highlighted that up-regulation of TRAPP, COG and Syntaxin can be observed 
in the mutant RPE up to the neonatal stage, but not at P7, when melanosome 
biogenesis is completed in the murine eye. From this information we deduce 
that Oa1 exerts its function in controlling melanosome targeted vesicle 
trafficking during melanosome formation and we do not know whether it 
acquires a different function after melanosome maturation. 
We further confirmed the reliability of the in vitro model in MNT1 cells by 
detecting upregulation of these same genes after siRNA treatment.  
Overall, these results suggest that Oa1 functions through regulation of 
proteins involved in vesicle trafficking events. The importance of the 
tethering complex in melanosome biogenesis is confirmed by a recent study in 
which a new mouse model for mosaic hypopigmentation (mhyp) is caused by 
mutations of another TRAPP subunit, Trappc6. The analysis of the phenotype 
in this albinism model showed that Trappc6 mutant RPE had patchy areas of 
depigmentation and smaller melanosomes (Gwynn B. et al., 2006). 
In summary, our in vivo studies on Oa1 null mouse and double mutant mice 
with Tyr and Matp together with molecular and morphological approaches in 
vivo and in vitro indicate that Oa1 is an intracellular GPCR lying on 
intracellular membranes (mature melanosomes and late endosomes) with a 
specific function fundamental for the identity of the melanosome. 
Malfunction of OA1 lead to two phenotypes, abundance of melanosomes 
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detectable at early stages of maturation and melanosomal size, detectable only 
in highly pigmented organelles. These two phenomena up to now were seen 
as two separated roles of OA1, however our results suggest that are probably 
based on a common defect. This hypothesis is based on the evidence that, in 
the absence of Oa1, vesicles containing markers of different membranous 
compartments can be detected. In fact, its signalling activity may control 
fusion or fission events between an intracellular compartment and 
melanosomes during their maturation, but also in between different 
melanosomal stages (Figure 25). In support of this idea come our molecular 
data showing a link between Oa1 and proteins that regulate vesicle tethering. 
OA1 probably functions by regulating proteins involved in vesicle trafficking 
events. The study of this interaction during melanosome biogenesis is a first 
step towards unraveling the mechanism through which Oa1 affects 
melanosome number and size and thus better understand the pathogenetic 
events underlying Ocular albinism type 1. 
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Figure 25. OA1 function model. Oa1 controls the abundance of melanosomes at early maturation stages 
(stage I), and melanosomal size, at later stages (stage IV). We speculate that OA1 exerts its role by 
regulating fusion or fission events between an intracellular compartment and melanosomes during their 
maturation, but also in between different melanosomal stages. 
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6.MATERIALS AND METHODS 
 
 
6.1 Mouse Breeding 
All the procedures on mice (including their euthanasia) were performed in 
accordance with ARVO Statement for Use of Animals in Ophthalmic and 
Vision Research and with institutional guidelines for animal research. Mice in 
this study were bred and maintained in a 12-hour light–dark cycle. Oa1-/- mice 
were bred on a C57BL/6 genetic background. In these mice, the first exon of 
the Oa1 gene is replaced by an Hprt cassette, eliminating the start codon and 
inactivating Oa1 protein formation (Incerti et al. 2000). Tyr c-2j and Matpuw 
mice, both on a C57BL/6 background, were purchased from the Jackson 
Laboratory (Bar Harbor, ME) and maintained inbred in the animal house. The 
Tyr c-2j allele is a recessive mutation due to a G-to-T base change at nucleotide 
291 resulting in an amino acid change from arginine to leucine at residue 77. 
No tyrosinase activity was found in hair bulb extracts from Tyr c-2j 
homozygous mice (Kwon et al. 1987). The Matpuw allele is due to a 7-bp 
deletion in exon 3 resulting in a 43 amino acid frameshift and premature stop 
codon, which predicts that the Matp protein lacks the C-terminal six-
transmembrane domains (Du et al. 2002). 
To generate Oa1-/-;Tyr c-2j/Tyr c-2j and Oa1-/-;Matpuw/Matpuw double-mutant 
mice, single homozygous mutant mice were crossed, and the resultant F1 
double-heterozigous progenies were intercrossed. F2 progeny was scored for 
coat color (Tyr c-2j/Tyr c-2j, Matpuw/Matpuw) and by diagnostic PCR on genomic 
DNA obtained from the tail for Oa1-/-. The primers used to genotype the Oa1 
null allele were the following: OA1f (ACA TGA CGC CCA ATC TCC 
CTC), OA1r (TAG ACT ACC CTC TGA GTC CAG), HPRTf (TAA GTT 
CTT TGC TGA CCT GCT), HPRTr (GGC TTT GTA TTT GCC TTT TCC). 
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6.2 Tyrosinase Activity Assay 
Eyes were dissected from killed littermates (P7) of different genotypes and 
frozen at -70°C. Each mouse was genotyped and at least four eyes for each 
genotype were used for the assay. Each pair of eyes was homogenized on ice 
in 10% glucose in PBS with 50 µg/ml leupeptin, 20 µg/ml aprotinin, and 5 
mM benzamide. Protein concentration was determined using the Bradford 
method (Bio-Rad, Hercules, CA). Equal quantities of protein were used in 
each reaction. After the addiction of tritiated tyrosine (GE Healtcare, 
Arlington Heights, IL) to the reaction, Tyr activity was assayed 
radiometrically by meseauring production of tritiated water from hydrolysis 
of tyrosine, as reported in a published protocol (Chiu et al. 1993). Activity 
was expressed as counts per million per microgram per hour of total protein. 
 
6.3 Quantitative RT-PCR  
Total RNA was extracted from wild type and Oa1-null either whole eyes or 
dissected RPE and retina at embryonic stage E14.5; wildtype and Oa1-null 
postnatal whole eyes at birth (P0) and 7 days after birth (P7); wild type and 
Oa1-null skin melanocytes (melanA, melanO); siOA1 (at 7 days of OA1 
interference in vitro, see below) human melanoma MNT-1 and control cells 
using RNeasy MiniKit (Quiagen, Milan, Italy) according to the 
manufacturer’s instructions. The same amount of cDNA for each genotype or 
treatment was synthesized using Superscript II (Invitrogen) and random 
primers. Real time PCR was carried out with the GeneAmp 7000 Sequence 
Detection System (Applied Biosystem). The RT-PCR reaction was performed 
using cDNA, 12.5 µl SYBR green master mix (Applied Biosystem) and 400 
nM primers for each gene (see list below). 
Water was added to a final reaction volume of 25 µl. the PCR conditions were 
as follows: preheating at 50°C for 2 min and 95°C for 10 min; 40 cycles of 15 
s at 95°C and 1 min at 60°C.  
  68 
Quantification results were expressed in terms of the cycle threshold (Ct). All 
real-time quantitative PCR reactions were run in triplicate and the Ct values 
were averaged from three independent samples. Data were normalized to the 
internal control, the reference genes (S26 for human samples and GAPDH for 
murine samples). Differences between the mean Ct values of each gene and 
those of the reference gene were calculated as ΔCt=Ctgene-Ctreference and 
represented as 2-ΔCt.  
 
Table 5. Sequences of the forward (f) and reverse (r) intron-spanning primers used 
 for Real-time quantitative PCRs: 
mouseGAPDHf GTA TGA CTC CAG TCA CGG CAA A 
mouseGAPDHr TTC CCA TTC TCG GCC TTG 
mouseTYRf CAA GGA TCT GGG ATA TGA CTA CAG C 
mouseTYRr GCT CAA TAT AAT TTC TGT AAA AGC CTG G 
mouseMATPf CCT CCA CTA CCA TGC CCT CCT 
mouseMATPr CCC AGT CTA TGG CAC CCA AA 
mouseOA1f GCT ATG CAG TTG ATG TAT ACT TGG TGA 
mouseOA1r GAT GTG GTA CAG CAG GAT GGT G 
mouseTRAPPC4f AGC TTA TGC TGG CCT CGA TG 
mouseTRAPPC4r ACT GCC CTG TTC CGG AGA TA 
mouseCOG4f CGC CTC TCT CAG ATG GCT ACA 
mouseCOG4r GGC CAG AGT TAG CAC CCA 
mouseSYTX5f CAG CAA TTG GCA CAC ATG GT 
mouseSYTX5r GGC TCC AAG CAC ATT CTC GT 
humanS26f CCG TGC CTC CAA GAT GAC AA 
humanS26r GCA ATG ACG AAT TTC TTA ATG GCC T 
humanOA1f CGG AGA TCG GCA GGA CTG AGC AC 
humanOA1r ATA GTG GGG GAT GGC GTG GT 
humanTRAPPC4f AGA CTT TGC CCT CAA GAA TCC A 
humanTRAPPC4r GGT TCT GGT CAA AGA GCT CAC AC 
humanCOG4f ACA AGT TTG CCC GGC TCT C 
humanCOG4r CCC CAG TAA TCG AGG ATC TCG 
humanSYTX5f CAG CTC ATT GAC GAG CAG GAT T 
humanSYTX5r CCT AGC ACG TTC TCG TCG ATC CTC 
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6.4 Antibodies 
We used the following primary antibodies: αPEP7, αPEP1, αPEP8, affinity-
purified rabbit antiserum to the carboxyl termini of murine melanogenic 
proteins respectively Tyrosinase, Tyrp-1 and Dct (Jimenez et al., 1991); 
polyclonal anti-Oa1, raised against the C-terminus (last 14 amino acids) of 
murine Oa1 (Cortese K., Giordano F. et al., 2005); rabbit polyclonal anti-
CRALBP (Nawrot et al., 2004); FITC- conjugated rat anti mouse Lamp1 (BD 
Bioscience); polyclonal anti EGFP (Molecular Probes); monoclonal anti flag 
M2 antibody (Sigma-Aldrich); polyclonal anti flag (Sigma Aldrich); 
monoclonal anti β-tubulin antibody (SIGMA, Milan, Italy); TA99 mouse anti-
TRP1 mAb (American Type Culture Collection; Thompson et al., 1985) for 
immunofluoscence and immunogold labelling and monoclonal anti-TRP1 
75KD (Abcam) for western blotting; anti-Lamp1 mouse mAb  (BD 
PharMingen); monoclonal anti-CD63 (Caltag Laboratories); melanoma Ab-2 
anti-Pmel17 (clone HMB50) (Lab Vision Corporation); mouse monoclonal 
anti-Pmel17 (clone HMB45) (Novocasta); rabbit anti-GM130 (Calbiochem); 
polyclonal anti-Rab1 (from Jaakko Saraste); monoclonal anti-Trappc-4 and 
anti Syntaxin-5 (Abnova Corporation); sheep anti-human TGN46 (AbD 
Serotec); rabbit anti mouse IgG was from Dakopatt; polyclonal anti biotin 
(Polysciences Biovalley).  
 
6.5 Western Blotting 
Eyes were dissected from either wild type or Oa1-null mice at different 
embryonic stages (E12.5, E14.5, E16.5) and postnatal ages (P0, P7, 3 
months), and proteins were extracted using the TRIzol reagent (Life 
Technologies), according to the manufacturer’s instructions and dissolved in 
1% SDS in PBS containing a protease inhibitor cocktail (Roche Diagnostic, 
Monza, Italy). Proteins were extracted from the Hela or melanocyte cultures 
with lysis buffer (1% Triton-X100, 1mM EDTA pH 8,0, 150mM NaCl, 
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20mM Tris pH 7,5) in the presence of protease inhibitor cocktail (Roche 
Diagnostic, Monza, Italy) on ice for 30 min. The lysed cells were then 
centrifuged at 21,000g for 20 min at 4°C. Protein concentrations were 
determined by Micro BCATM Protein Assay Reagent Kit (Pierce). The protein 
samples were mixed with an equal volume of loading buffer containing 2% 
SDS and 5% β-mercaptoethanol and then boiled for 2 min. To detect OA1-
tagged protein, protein samples were mixed with an equal volume of 14% 
SDS and warmed at 37°C for 5 min. In fact, lower SDS concentration or 
boiling were avoided due to the precipitations of the OA1 protein under these 
conditions. Equal amount of proteins were loaded and separated in an 8% 
SDS-PAGE gel. The separated proteins were then transfered to 
polyvinylidene difluoride membrane (Millipore) and the membreanes were 
blocked in PBS/0.1%Tween-20 (PBS/T) with 5% nonfat dried milk, 
incubated with primary antibody in PBS/T, washed four times in blocking 
solution, and incubated with horseradish peroxidase-conjugated secondary 
antibody (anti-rabbit or anti-mouse; 1:10000; Jackson ImmunoResearch 
Laboratories) followed by washing in PBS/T. Visualization of the antibody 
binding was carried out with ECL Plus Western blotting detection system (GE 
Healthcare) according to the manufacturer’s instruction. 
 
6.6 Cells and culture conditions  
Melanocytes, MNT-1 and Hela cells: 
The immortal Oa1 null and wild type melanocytes cell lines were derived 
from wild type or Oa1-/- C57Bl/6 mouse skin (obtained from E.Sviderskaya). 
Cells were maintained in RPMI-1640 supplemented with 10%FCS and 
200nM phorbol 12-myristate 13-acetate at 37°C with 10% CO2. 
MNT-1 human melanoma cells were maintained in DMEM supplemented 
with 10% AIM-V medium (Life Technologies), 20% FCS, non-essential 
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aminoacids, and sodium pyruvate. Hela cells were cultured in DMEM with 
10% FCS. 
Primary RPE cell culture: 
Primary retinal pigment epithelium cells (RPE) and choroidal melanocytes 
were isolated from P1 eyes of wild-type, Oa1-/-, Tyr c-2j and Matpuw mice. 
After a brief (30 sec-1 min) treatment with 2 mg/ml Dispase II (Roche , 
Indianapolis, IN) in Hanks’ balanced salt solution (Invitrogen) choroids and 
RPE were gently separated from neural retina, lens, and vitreous and 
incubated in 2 ml of 0.5 mg/ml trypsin (Sigma-Aldrich, St.Louis, MO) in 
Hanks’ at 37C for 30 minutes. 
After adding 1 volume of 0.2 mg/ml trypsin inhibitor (Roche) in DMEM 
(Invitrogen), the tissue was triturated 50 times with a borehole glass pipette. 
The single-cell suspension was resuspended in 1 ml/eye DMEM-Ham’s F12 
1:1 (Invitrogen) containing 5% FBS and N2 hormone mix (Invitrogen) and 
plated on extracellular matrix (ECM) gel (SIGMA) at 37°C in a 5% CO2 
atmosphere. Cells were cultured for 4 to 5 days and not propagated in culture. 
Cell identity was defined by pigmentation and by expression of Tyr, Tyrp-1 
and Tyrp-2 for RPE and choroidal melanocytes and by CRALBP for RPE 
cells.  
 
6.7 Immunofluorescence (IF)  
Cells were grown on glass coverslips (coated with ECM for RPE primary 
cells) and transfected with plasmid constructs or siRNA. Cells on coverslips 
were rinsed in PBS, fixed for 15min with 4% paraformaldehyde/PBS, rinsed 
again and permeabilized with 0.1% saponin in PBS. After 30 min of blocking 
the cells were incubated with primary antibodies for 1,5 h, washed several 
times and incubated with Alexa 488- or Alexa 568-conjugated anti-rabbit or 
anti-mouse secondary antibodies (1:200; Molecular probes) and washed 
again. All incubations and wash steps were performed with PBS/BSA/0.01% 
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saponin. Coverslips were mounted in mowiol mounting medium, viewed on a 
Microscope Leica DM 6000 and the images were obtained with the 
Metamorphe software. 
Immunofluorescences on RPE primary cells were visualized with a laser 
confocal microscope system (Leica, Heidelberg, Germany) and the images 
were processed with Photoshop 7 (Adobe).  
 
6.8 Electron Microscopy (EM) 
Ultrastructural Analysis of Retina Pigment Epithelium (in collaboration with 
Prof. C. Tacchetti , University of Genova): 
P7 and 3 month-old mice of different genotypes were anesthetized and 
perfused with 4% paraformaldehyde and 2% glutaraldehyde in PBS. Eyes 
were removed and placed in 0.1 cacodylate buffer, containing 2.5% 
glutaraldehyde, for 3 hours at room temperature. Eyes were postfixed in OsO4 
for 1 hour and uranyl acetate for another hour. Subsequently, samples were 
dehydrated through a graded ethanol series and propylene oxide and 
embedded in resin (Poly-Bed; Polysciences, Inc., Warrington, PA) overnight 
at 42°C and 2 days at 60°C. A dorsoventral orientation was maintained during 
embedding. Semithin sectioning (0.5 µm) was started at the frontal pole of the 
embedded eye (corresponding to the cornea) and ultrathin sections (50 nm) 
were collected, starting when the RPE was observed. Ultrathin sections were 
stained with uranyl acetate and lead citrate and observed with an electron 
microscope (model CM10 or model G2 Tecnai; Philips, Eindhoven, The 
Netherlands). Comparable regions of the different genotypes were analyzed.  
The number of melanosomes and their maturation stages in the RPE of single- 
and double-mutant mice were counted on 10 random micrographs at X21.000, 
either at the apical zone or the basal zone of the epithelium. The basal zone 
was defined by the presence of basal lamina, the apical zone by the presence 
of microvilli, and the limit between the two regions was drawn at half 
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distance between the apical and basal surfaces. Diameters were measured on 
melanosomes at different stages of maturation (stage II, III and IV) in each 
micrograph (Photoshop 7.0 software; Adobe System, Mountain View, CA). 
For statistical analysis we applied unpaired t-test assuming equal variances. 
Ultrastructural analysis and immunogold labeling of cultured cells: 
For conventional EM, cells grown on coverslips were fixed with 2.5% 
glutaraldehyde in 0.1M cacodylate buffer for 24 h. After several washes with 
0.1M cacodylate buffer, the cells were postfixed with 2% OsO4, dehydrated 
in ethanol, and embedded in Epon while on the coverslips. Ultrathin sections 
were prepared and counterstained with uranil acetate and lead citrate before 
the observation. 
For immunogold labelling, cells were fixed with a mixture of 2%PFA and 
0.2% glutaraldehyde in 0.1M phosphate buffer, pH 7.4. Cells were scraped in 
0.1M phosphate buffer containing 1% gelatin and pelleted in 10% gelatin. 
The cell pellets were solidified on ice and cut into small blocks, which were 
infused in 2.3M sucrose overnight at 4°C for cryoprotection. Afterwards, the 
blocks were mounted on aluminium pins and frozen in liquid nitrogen. 
Ultrathin cryosectioning and immunogold labelling were done as described 
(Raposo et al. 1997). Briefly, ultrathin (~65 nm) cryosections were prepared 
with an Ultracut FCS ultracryotome (Leica), and single- or double-
immunogold labelled with antibodies and protein A coupled to 5 or 10 or 15-
nm gold, as indicated in the legends to the figures. Ultrathin cryosections 
were retrieved with a mixture of methylcellulose and uranyl acetate (Liou et 
al. 1996) for better preservation of membranes. Sections were analyzed on 
Philips CM120 electron microscope, equipped for cryo-EM and with a 
1Kx1K GATAN SSC camera. 
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6.9 Cloning of OA1-tagged constructs 
The human OA1 coding sequence was amplified by polymerase chain 
reaction (PCR) by using Pfu DNA polymerase (Promega) and the following 
primers containing EcoRI and XhoI restriction sites: OA1f: 
CGGAATTCATGACCCAGGCAGGCCGG;OA1r:CCGCTCGAGTCACACC
TGGACACGGAAG. The PCR product was digested by EcoRI and XhoI and 
subsequently cloned into EcoRI/XhoI-digested pcDNA3 vector (pRIZZO-
flag) to express OA1 with a Flag-tag at the C-terminal. The same PCR 
product was also cloned into pEGFP-N1 vector (Invitrogen) to express 
OA1with an EGFP-tag at the C-terminal. 
 
6.10 Transfection and siRNA interference 
NMT1 and HeLa cells were grown on glass coverslips and transfected with 
plasmid constructs using Lipofectamine 2000 (Invitrogen) following 
manufacturer’s recommendations. Cells were analyzed after 48 h.  
Three synthetic siRNA duplex oligomers (21-mers) targeting human OA1 
(first: GGA UAU GAA CCA CAC GGA A; second: GGC UGU AAA GUA 
AGU GUA A; third: GGU UGU CGA AUA UCA UCA A) were designed 
and then ordered from QIAGEN. As control, a non-targeting control siRNA 
was used. Cells were transfected using Oligofectamine (Invitrogen) according 
to the manifacturer’s instructions. The final concentration of siRNA oligos 
was 1 µM. Cells were subjected to two rounds of transfection on day 0 and 4, 
were passaged as required, and were analyzed on day 7.  
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6.11 Transferrin incorporation 
OA1 interfered and control MNT-1 cells were washed with serum-free 
medium seven days after transfection and starved for 45 min before 
incubation with biotin-conjugated transferrin (60 µg/ml) (Sigma-Aldrich) 
continuously for 45 min at 37°C. After washing with ice-cold medium, cells 
were fixed and processed for ultracryotomy. 
 
6.12 Melanin content assay 
OA1 interfered and control MNT-1 cells were disrupted by sonication in 50 
mM Tris-HCl, pH 7.4, 2 mM EDTA, 150 mM NaCl, 1 mM dithiothreitol and 
protease inhibitors seven days after transfection. Pigment was pelleted at 
20,000g for 15 min at 4°C, rinsed once in ethanol/ether (1:1), and dissolved in 
2M NaOH/ 20% dimethylsulfoxide at 60°C. Melanin content was measured 
as optical density at 492 nm. 
 
6.13 Microarrays (in collaboration with Dr. Stefano Volinia, University of 
Ferrara) 
The detailed procedure used for DNA microarray analysis is available at: 
http://biotecnologie.unife.it/microarrays/. Briefly, 3µg of total RNA, isolated 
using an RNeasy Mini Kit (Qiagen) from wild type and OA1 null E14.5 
embryonic eyes derived from the same litter, were used to derive 
fluorescently labelled cDNAs, which were hybridized on Affimetrix mouse 
whole genome chip (GeneChip® Mouse Genome 430 2.0). The experiments 
of microarray were repeated with three different biological samples. 
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The Ocular Albinism Type 1 (OA1) Gene Controls
Melanosome Maturation and Size
Katia Cortese,1,2 Francesca Giordano,2,3 Enrico M. Surace,3 Consuelo Venturi,1
Andrea Ballabio,1,4 Carlo Tacchetti,1 and Valeria Marigo3
PURPOSE. The authors took advantage of the Oa1mutant mouse
in combination with other albinism mouse models (i.e., Tyrosi-
nase and membrane-associated transporter protein [Matp]) to
study the function of Oa1, the gene mutated in ocular albinism
type 1, in the RPE during development and after birth.
METHODS. Enzyme activity and protein localization were ana-
lyzed by immunohistochemistry of tyrosinase (Tyr) in Oa1-null
mice. Ultrastructural analysis and morphometry were per-
formed by electron microscopy, of the RPE in Oa1-knockout
mouse and double-mutant mice of Oa1 with either Tyr or Matp.
RESULTS. Differently from other albinism models, Tyr activity
was not impaired in Oa1/ eyes. Hypopigmentation of the
RPE in Oa1/ mice is due to a reduced number of melano-
somes. Analysis of Oa1/;Tyrc-2J/Tyrc-2J and Oa1/;Matpuw/
Matpuw double-knockout mice, which display a block at stages
II and III of melanosome maturation, respectively, revealed that
Oa1 controls the rate of melanosome biogenesis at early stages
of the organellogenesis, whereas the control on the organelle
size is exerted at the final stage of melanosome development
(stage IV).
CONCLUSIONS. The findings indicate that Oa1 is involved in the
regulation of melanosome maturation at two steps. Acting at
early maturation stages, Oa1 controls the abundance of
melanosomes in RPE cells. At later stages, Oa1 has a function
in the maintenance of a correct melanosomal size. This
study helps to define ocular albinism type 1 as a defect in
melanosome organellogenesis and not in melanin produc-
tion. (Invest Ophthalmol Vis Sci. 2005;46:4358–4364) DOI:
10.1167/iovs.05-0834
The X-linked form of albinism (ocular albinism type 1) inhumans is due to mutations in the ocular albinism type 1
(OA1, recently renamed GPR143) gene.1 Although skin pig-
mentation appears normal, patients manifest the characteristic
defects of albinism in the eye, such as translucent iris, photo-
phobia, foveal hypoplasia, nystagmus, and miswiring of the
optic tract. Studies conducted in the mouse showed that Oa1
is specifically expressed in pigment cells of skin and eye.2 OA1
protein localizes on the membrane of mature melanosomes3
and in the endolysosome–premelanosome compartment.4 The
protein has homology with members of the G protein-coupled
receptor (GPCR) superfamily and binds heterotrimeric G pro-
teins (Gi)
5; however, a ligand has not been identified yet. The
Oa1-null mouse was generated by knocking out the first exon
of the mouse gene.6 As observed in humans, Oa1 loss of
function causes the formation of abnormally giant melano-
somes (macromelanosomes). Macromelanosomes were de-
tected in the retinal pigment epithelium (RPE) of these mice
after birth. Electron microscopy demonstrated that macromela-
nosomes contain a central core region within the electron-
dense melanin, which closely resembled the structure of a
normal membrane-free melanosome.6 This result suggested a
mechanism of macromelanosome formation based on over-
growth of a single melanosome rather than fusion of several
melanosomes. Nevertheless, the function of Oa1 during mela-
nosome maturation is still obscure. Furthermore, the correla-
tion between macromelanosome and the hypopigmentation of
the RPE that causes the albinism phenotype in patients is
unclear.
Melanosomes are organelles specialized in the biosynthesis
and storage of melanin,7 in melanocytes of skin and ear, and in
RPE cells. Melanosome maturation occurs through sequential
maturation stages (I–IV) that can be defined based on morphol-
ogy.8 Stage I premelanosomes lack pigment and contain inter-
nal membranous vesicles. Stage II melanosomes are elongated
in shape, lack pigmentation and contain intraluminal matrix
fibers organized in a striated array. Deposition of black melanin
along the matrix fibers begins in stage III melanosomes. Finally,
stage IV melanosomes are characterized by a dense homoge-
neous deposit of melanin that covers all the internal structures
of the matrix.8 Melanin is synthesized from the amino acid
tyrosine. In the initial step, tyrosine is hydroxylated to L-DOPA,
which is in turn oxidized to dopaquinone. Both steps are
catalyzed by the enzyme tyrosinase (Tyr). Then dopaquinone is
converted into melanin.
There is no evidence of differences in melanosome organel-
logenesis between RPE and skin melanocytes. However, in
contrast to skin melanocytes that transfer their melanosomes
to surrounding keratinocytes in the epidermis,9 ocular melano-
somes are retained.10 Melanization in RPE cells apparently
occurs only for a limited period after initial differentiation, and
then they permanently halt melanin synthesis.11
Mouse mutants have been of great value for the elucidation
of the pigmentation process. The albino (c) mouse is a spon-
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taneous mutant with a mutation in the Tyr gene, causing loss of
tyrosinase enzyme activity and lack of pigmentation. Recently,
the molecular basis of the underwhite (uw) mouse has been
defined.12 The affected gene encodes the membrane-associ-
ated transporter protein (Matp). An in vitro study on Matpuw
mutant melanocytes suggested that this mutation causes abnor-
mal processing and intracellular trafficking of Tyr to the mela-
nosome.13 These two spontaneous albino mutants show differ-
ent phenotypes in the RPE. The Tyrc mouse completely lacks
melanin, and melanosomes do not develop beyond stage II.
Ultrastructural studies of different Matp alleles suggested that
the defect was at the level of the melanosome showing irreg-
ular shape, reduced size, and maturation impairment.14 There-
fore, these two mouse models provided us with genetic tools
to study Oa1 function, either in the absence of melanin pro-
duction or in impaired melanosomal maturation conditions.
In this study, we addressed the function of Oa1 in pigment
cells in vivo, to define better why mutations in OA1 cause
albinism. We generated double-mutant mice of Oa1 and either
Tyrc-2J or Matpuw and analyzed melanosome phenotype in the
absence of melanin synthesis and impaired melanosome mat-
uration. The phenotype of the double-mutant mice compared
with single mutants led us to the hypothesis that Oa1 performs
two functions in melanogenesis. In particular, Oa1 loss of
function causes a reduction in the number of melanosomes in
the RPE, suggesting an Oa1 control on the rate of melanosome
biogenesis. In addition, double mutant phenotype analysis un-
raveled a size-control function of Oa1 on the final maturation
stage of melanosomes (stage IV).
MATERIAL AND METHODS
Mouse Breeding
The use of animals in this work was in accordance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision Research.
Mice were bred and maintained in a 12-hour light–dark cycle. Oa1/
mice were bred on a C57BL/6 genetic background. Tyrc-2J and Matpuw
mice, both on a C57BL/6 background, were purchased from the Jack-
son Laboratory (Bar Harbor, ME) and maintained inbred in the animal
house. The Tyrc-2J allele is a recessive mutation due to a G-to-T base
change at nucleotide 291 resulting in an amino acid change from
arginine to leucine at residue 77. No tyrosinase activity was found in
hair bulb extracts from Tyrc-2J homozygous mice.15 The Matpuw allele
is due to a 7-bp deletion in exon 3 resulting in a 43 amino acid
frameshift and premature stop codon, which predicts that the Matp
protein lacks the C-terminal six-transmembrane domains.16
To generate Oa1/;Tyrc-2J/Tyrc-2J and Oa1/;Matpuw/Matpuw
mice, single homozygous mutant mice were crossed, and the resultant
F1 double-heterozygous progenies were intercrossed. F2 progeny was
scored for coat color (Tyrc-2J/Tyrc-2J, Matpuw/Matpuw) and by diagnos-
tic PCR on genomic DNA obtained from the tail for Oa1/.
Tyrosinase Activity Assay
Eyes were dissected from killed littermates (P7) of different genotypes
and frozen at70°C. Each mouse was genotyped and at least four eyes
for each genotype were used for the assay. Each pair of eyes was
homogenized on ice in 10% glucose in PBS with 50 g/mL leupeptin,
20 g/mL aprotinin, and 5 mM benzamide. Protein concentration was
determined using the Bradford method (Bio-Rad, Hercules, CA). Equal
quantities of protein were used in each reaction. After the addition of
tritiated tyrosine (GE Healthcare, Arlington Heights, IL) to the reaction,
Tyr activity was assayed radiometrically by measuring production of
tritiated water from hydrolysis of tyrosine, as reported in a published
protocol.17 Activity was expressed as counts per million per micro-
gram per hour of total protein.
Quantitative RT-PCR
Eyes were dissected from either wild-type or Oa1-null mice at birth
(P0), and total RNA was extracted (TRIzol reagent; Invitrogen-Life
Technologies, Gaithersburg, MD), according to the manufacturer’s
instructions. cDNAs were synthesized (Superscript II; Invitrogen, Carls-
bad, CA) and random primers and then amplified (SYBRR Green PCR
Master Mix; Applied Biosystems, Inc. [ABI], Foster City, CA) with the
forward (f) and reverse (r) intron-spanning primers: GAPDHf (GTAT-
GACTCCAGTCACGGCAAA) and GAPDHr (TTCCCATTCTCGGCCTTG)
for glyceraldehyde-3-phosphate; TYRf (CAAGGATCTGGGATATGAC-
TACAGC) and TYRr (GCTCAATAT AATTTCTGTAAAAGCCTGG) for
Tyr; and MATPf (CCTCCACTACCATGCCCTCCT) and MATPr
(CCCAGTCTATGGCACCCAAA) for Matp. Quantitative PCR reactions
were run in triplicate for each gene (model 7000; ABI). Cyclical
reaction values were recorded and preprocessed with the accompany-
ing software (ABI). Data were then normalized to the internal control
and statistically analyzed (t-test).
RPE Cell Culture
Primary retinal pigment epithelium cells (RPE) and choroidal melano-
cytes were isolated from P1 eyes of wild-type, Oa1/, Tyrc-2J and
Matpuw mice.
After a brief (30-minute) treatment with 2 mg/mL Dispase II
(Roche, Indianapolis, IN) in Hanks’ balanced salt solution (Invitrogen)
choroid and RPE were gently separated from neural retina, lens, and
vitreous and incubated in 2 mL of 0.5 mg/mL trypsin (Sigma-Aldrich, St.
Louis, MO) in Hanks’ at 37°C for 30 minutes.
After adding 1 volume of 0.2 mg/mL trypsin inhibitor (Roche) in
DMEM (Invitrogen), the tissue was triturated 50 times with a borehole
glass pipette. The single-cell suspension was resuspended in 1 mL/eye
DMEM-Ham’s F-12 1:1 (Invitrogen) containing 5% FBS and N2 hormone
mix (Invitrogen) and plated on extracellular matrix (ECM) gel (Sigma)
at 37°C in a 5% CO2 atmosphere. Cells were cultured for 4 to 5 days
and not propagated in culture. Cell identity was defined by pigmenta-
tion and by expression of Tyr, Trp1, and Trp218–20 for RPE and
choroidal melanocytes and by Cralbp for RPE cells.21
Immunofluorescence
Cells were fixed in 4% paraformaldehyde/PBS, permeabilized with
0.1% saponin in 10%FBS/PBS and incubated with polyclonal antibodies
anti-Oa1, raised against the C terminus (last 14 amino acids) of murine
Oa1, anti-Tyr,19 anti-Cralbp21 in 0.01% saponin, 1% FBS/PBS. Alexa
Fluor goat anti-rabbit was used as the secondary antibody (Molecular
Probes, Eugene, OR). Immunofluorescence was visualized with a laser
confocal microscope system (Leica, Heidelberg, Germany).
Ultrastructural Analysis
P7 and 3-month-old mice of different genotypes were anesthetized and
perfused with 4% paraformaldehyde and 2% glutaraldehyde in PBS.
Eyes were removed and placed in 0.1 M cacodylate buffer, containing
2.5% glutaraldehyde, for 3 hours at room temperature. Eyes were
postfixed in osmium tetroxide for 1 hour and uranyl acetate another
hour. Subsequently, samples were dehydrated through a graded etha-
nol series and propylene oxide and embedded in resin (Poly-Bed;
Polysciences, Inc., Warrington, PA) overnight at 42°C and 2 days at
60°C. A dorsoventral orientation was maintained during embedding.
Semithin sectioning (0.5 m) was started at the frontal pole of the
embedded eye (corresponding to the cornea) and ultrathin sections
(50 nm) were collected, starting when the RPE was observed. Ultrathin
sections were stained with uranyl acetate and lead citrate and observed
with an electron microscope (model CM10 or Model G2 Tecnai;
Philips, Eindhoven, The Netherlands). We analyzed comparable re-
gions of the different genotypes.
The number of melanosomes and their maturation stages in the RPE
of single- and double-mutant mice were analyzed on 10 random micro-
graphs at 21,000, either at the apical zone or the basal zone of the
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epithelium. The basal zone was defined by the presence of basal
lamina, the apical zone by the presence of microvilli, and the limit
between the two regions was drawn at half distance between the
apical and basal surfaces. Diameters were measured on melanosomes
at different stages of maturation (II, III and IV) in each micrograph
(Photoshop 7.0 software; Adobe Systems, Mountain View, CA). For
statistical analysis, we applied unpaired t-test assuming equal variances.
RESULTS
Effect of Oa1 Loss of Function on Tyr activity and
the Rate of Melanosome Biogenesis in the RPE
The albino phenotype in patients with ocular albinism type 1
is often correlated with macromelanosome formation; how-
ever hypopigmentation of the ocular fundus could not simply
be explained by giant melanosomes. In fact, melanin appears
to be synthesized in the absence of OA1, as suggested by
pigmentation of skin and hair in patients. To quantify this
observation, we measured activity of Tyr in eye protein ex-
tracts from the Oa1 mutant, heterozygous, and wild-type mice
7 days after birth (P7) and found no significant difference
among the different genotypes (Fig. 1). Therefore, in contrast
to other albinism models,22 lack of Oa1 does not impair Tyr
activity in the eye. It is otherwise possible that albinism in OA1
is due to a decreased abundance of melanosomes in the RPE. In
one of our previous studies, based on light microscopy analy-
sis, we failed to detect differences in pigment granule number
in the RPE of Oa1-knockout mice.6 We therefore chose a more
sensitive technique, such as morphometric studies by electron
microscopy. We evaluated density (number of organelles per
square micrometer) and distribution of melanosomes in the
RPE of wild-type and Oa1 mutant mice at different develop-
mental and postnatal stages. At embryonic day (E)15.5, new-
born (P0), and later postnatal stages (P7 and 3 months), the
melanosome population in wild-type RPE comprised mostly
mature stage-IV melanosomes (Table 1). However, a sizable
fraction of the melanosomes was still at stage II at E15.5 (31%),
and at stage III at P0 (14%). The total number of melanosomes
increased progressively and reached a plateau at P7 (Table 1).
The changes in the total number of melanosomes reflected
almost exclusively the modifications in the stage-IV population,
probably due to the relative paucity of stages II and III at P0,
P7, and 3 months (Table 1).
In Oa1 mutant RPE we found that the melanosome popu-
lation, similar to wild-type RPE, comprised mostly stage IV
melanosomes (Table 1), which included also macromelano-
somes at P0, P7, and 3 months. Similar to the phenotype
described in patients,23 only a fraction of melanosomes was
enlarged, and we calculated that approximately 20% of mela-
nosomes in the RPE displayed the macromelanosome pheno-
type (1.5 m; Table 2). Of note, when compared with wild-
type RPE, the total number of melanosomes was lower,
showing 25% reduction at E15.5 (P  0.05), 40% at P0, 50% at
P7, and 57% at 3 months (P  0.01, Table 1). A more detailed
analysis of the relative changes among different stages of mela-
nosomes revealed that the reduction was mostly attributable to
the stage-IV population at P0, P7, and 3 months, whereas at
E15.5, it was due to changes in immature stage II melanosomes
(Table 1). With respect to the cellular distribution of melano-
somes, Oa1 mutants did not show differences when compared
with wild-type RPE (data not shown).
The reduced number of stage-IV melanosomes was not
accompanied by the appearance of autophagosomes, suggest-
ing that the event was probably due to a reduced rate of
melanosome biogenesis, rather than degradation of already
formed organelles.
Effect of Oa1/, Tyrc-2J, and Matpuw Mutations
on Each Other and Cellular Distribution
Our analysis of the Oa1 mutant RPE suggested that Oa1 is
involved in controlling both the rate of melanosome biogenesis
and the size of stage-IV melanosomes. To define which stage of
melanosome maturation was the target of Oa1 activity, we
generated double-mutant mice of Oa1 with two other albinism
mouse models (i.e., Tyrc-2J and Matpuw) in which melano-
somes are unable to undergo full maturation. Although in
Tyrc-2J mice melanin is not synthesized and melanosomes stop
their maturation at stage II (Fig. 4B), in Matpuw mice, the
mutation causes a block of maturation at stage III (Ref. 24 and
Fig. 4B). The double mutant strategy would have only been
successful if each pair of selected gene mutations did not
interfere with their reciprocal expression and/or distribution.
Therefore, before generating double-mutant mice we analyzed
expression and distribution of Oa1 protein in Tyrc-2J and
Matpuwmutants. To this end, we generated primary cultures of
pigment cells dissected from wild-type, Oa1/, Tyrc-2J, and
Matpuw neonatal eyes. These cultures contained both RPE and
choroidal cells as defined by immunodetection of pigment cell
markers (i.e., Tyr, Tyrp1, and Tyrp2, data not shown). To
discriminate between the two cell populations, we performed
FIGURE 1. Tyrosinase activity assay on eyes at the age of 7 days after
birth. ANOVA confirmed no significant difference in the enzymatic
activity among wild-type (wt, n  9), Oa1 heterozygous (Oa1/, n 
9), and homozygous (Oa1/, n  6) mice. Tyrosinase activity in
albino control CD1 mice was significantly different from that in wild-
type (t-test P  0.001). Data are shown as the mean divided by the
blanc (CD1 mice that have no Tyr activity have a value close to 1,
therefore activity equal to blanc).
TABLE 1. Number of Melanosomes in the RPE of Wild-Type and
Oa1/ Mice at the Different Developmental Stages
Stage
Area m2II III IV
Wild-type
E15.5 9 1 18 186
P0 3 13 75 186
P7 0 4 132 186
3 months 9 2 136 186
Oa1/
E15.5 2 2 17 186
P0 10 8 37 186
P7 0 4 63 186
3 months 0 5 58 186
The total area of the cell analyzed (area) was determined by the
point-intersection method and expressed in square micrometers.29
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immunofluorescence studies using antibodies to Cralbp, a spe-
cific marker for RPE cells21 and confirmed that cells with
elliptic big pigment granules were RPE cells (Fig. 2, inset). As
expected, labeling with an Oa1-specific antibody demonstrated
colocalization of Oa1 with pigmented granules in wild-type cell
cultures, whereas no signal was detected in Oa1/ cells. Oa1
was normally expressed and distributed in Tyrc-2J and Matpuw
mutant RPE and choroidal melanocytes (Fig. 2).
We then analyzed expression of Tyr andMatpmRNA in Oa1
mutant eyes at birth by quantitative real-time PCR. Tyr and
Matp expression was not impaired in the Oa1/ genotype
compared with the wild-type (Fig. 3A, 3B). Finally, we analyzed
Tyr distribution in RPE and choroidal melanocyte primary
cultures derived from Oa1/ neonatal eyes. We found that
Oa1 loss of function did not affect Tyr distribution (Figs. 3E,
FIGURE 2. Oa1 expression and distribution in Tyrc-2J and Matpuw
eyes. Pigmented cells dissociated from eyes of neonatal wild-type (wt),
Oa1/, Tyrc-2J, and Matpuw mice were stained with an anti-Oa1
antibody. The identity of RPE cells was assessed by staining with
anti-Cralbp antibody (inset), which does not label choroidal pigmented
cells (arrow). Top: interferential reflection micrographs of a typical
RPE (left) and choroid (right) cell. Bottom: immunofluorescence de-
tection of Oa1 in wild type, Oa1/; Tyrc-2J, and Matpuw in RPE and
choroidal cells. Expression of Oa1 in Tyrc-2J and Matpuw RPE and
choroidal cells was similar to wild-type, whereas Oa1 could not be
detected, as expected, in Oa1/ RPE, and choroid.
FIGURE 3. Tyrosinase and Matp expression in Oa1 mutant eyes. (A)
Real-time quantitative RT-PCR of Tyr in neonatal (P0) wild-type (wt),
and Oa1/ (Oa1 mut) eyes. y-Axis: 2(dCt) value represents differ-
ences between the mean Ct (cycle threshold) values of tested genes
and those of reference gene. (B) Real-time quantitative RT-PCR ofMatp
in neonatal (P0) wild-type (wt) and Oa1/ (Oa1 mut) eyes. (C–F)
Immunofluorescence analysis of Tyr distribution in RPE (arrows) and
choroid-dissociated cells. (C, E) Micrographs of cells derived from
wild-type mice, (D, F) micrographs of cells derived from Oa1/mice,
(C) and (D) are bright-field phase images of the cells in (E) and (F),
respectively.
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3F). Therefore, the absence of Oa1 does not interfere with the
expression of Tyr and Matp.
Altogether, these results suggest that Oa1, Tyr, and Matp do
not reciprocally influence each others expression and subcel-
lular distribution.
Effect of Oa1 on Rate of Melanosome Biogenesis
and Organelle Size
We generated Oa1/;Tyrc-2J/Tyrc-2J double-mutant mice and
analyzed the melanosome phenotype in RPE at P7. At this time
point, both the reduced number of melanosomes and the
macromelanosome phenotype are easily detectable in Oa1-null
mice (Tables 1, 2; Ref. 6). At P7, no melanin was deposited in
the melanosomes of Tyrc-2J/Tyrc-2J single-mutant or Oa1/;
Tyrc-2J/Tyrc-2J double-mutant RPE, and melanosomes stopped
their maturation at stage II (Fig. 4, Table 3). Of interest, the
number of stage II melanosomes was reduced in the Oa1/;
Tyrc-2J/Tyrc-2J double-mutant compared with the Tyrc-2J/Tyrc-2J
single-mutant RPE (Table 3).
We then evaluated whether the size of melanosomes was
affected by the combination of the two mutations. To this
purpose, we compared the diameter at P7 of the most mature
stages in each genotype (i.e., stage II in Tyrc-2J/Tyrc-2J and
Oa1/;Tyrc-2J/Tyrc-2J and stage IV in Oa1/). Stage II mela-
nosomes had an average diameter of 0.56 m in Tyrc-2J/Tyrc-2J
single mutant RPE and of 0.67 m in the double mutant RPE
(Table 2). These values were similar to those obtained from
wild-type stage-IV melanosomes (average value, 0.51 m; Table
2). On the contrary, they were smaller compared with Oa1/
macromelanosomes (average value, 0.9 m; Table 2).
The reduced number of stage-II melanosomes in double-
mutant RPE demonstrates that Oa1 contributes to the rate of
melanosome maturation at early stages and independently of
melanin synthesis. However, we could not define yet whether
melanin synthesis and/or melanosome maturation are neces-
sary for the regulation of melanosomal size by Oa1.
Effect of Melanosome Maturation
To address whether melanin deposition and/or melanosome
maturation are involved in the macromelanosome phenotype,
we analyzed the RPE in P7 and 3 month old Oa1/;Matpuw/
Matpuw double-mutant mice. In fact Matpuw/Matpuw adult
FIGURE 4. Ultrastructural analysis of RPE melanosomes in different
genotypes. (A) Micrographs of RPE cells from wild-type and Oa1/
mice at P7. Photographs are at the same magnification and show the
difference in size of the melanosomes in the two animals. Bar, 2.55 m.
(B) Micrographs of RPE melanosomes from Tyrc-2J/Tyrc-2 and Oa1/;
Tyrc-2J/Tyrc-2 and Matpuw/Matpuw and Oa1/;Matpuw/Matpuw mu-
tant mice. Arrows: representative stage-II melanosomes. Different
stages of melanosomes were found in RPE of Matpuw/Matpuw single
and Oa1/;Matpuw/Matpuw double-mutant mice. Arrowheads: stage
III melanosomes. Bar, 0.47 m.
TABLE 2. Size Distribution of Melanosomes in the RPE of
Different Genotypes
Diameter
Mean
Diameter
(m)
<1
m
1–1.5
m
>1.5
m
Stage IV
Wild-type
P7
% 90 10 0 0.51
n 106 11 0
3 months
% 92 8 0 0.61
n 98 9 0
Oa1/
P7
% 63 14 23 0.90
n 30 7 11
3 months
% 44 40 16 1.00
n 21 19 8
Stage II
Tyrc-2J/Tyrc-2J
P7
% 100 0 0 0.56
n 118 0 0
Oa1/;Tyrc-2J/Tyrc-2J
P7
% 95 5 0 0.67
n 41 2 0
Stage III
Matpuw/Matpuw
3 months
% 87 13 0 0.54
n 14 2 0
Oa1//Matpuw/Matpuw
3 months
% 97 3 0 0.56
n 40 1 0
Data report the number (n) and the percentage (%) of the mela-
nosomes counted in each condition and falling in each of the three
ranges of diameter shown.
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RPE was previously reported to display smaller but pigmented
melanosomes.14 Whereas at P7 we did not detect any melano-
some in both Matpuw/Matpuw and double-mutant mice (data
not shown), at 3 months of age, in both genotypes RPE mela-
nosomes did not proceed beyond stage III (Table 3). The
Matpuw/Matpuw single mutant showed a reduction in melano-
some number compared with the Oa1/;Matpuw/Matpuw
double mutant, though the difference is not significant. By
morphometry, we measured similar diameters in the Matpuw/
Matpuw single mutant (0.54 m) and in the Oa1/;Matpuw/
Matpuw double mutant (0.56 m) RPE (Table 2C). However,
when analyzed in detail, the relative distribution of the differ-
ent stages of melanosome showed a reduction in the number
of stage-II melanosomes in the double-mutant compared with
Matpuw/Matpuw single-mutant RPE (Table 3). This event was
accompanied by an increased percentage of stage-III melano-
somes (75% of total melanosomes) in Oa1/;Matpuw/Matpuw
double-mutant RPE when compared with Matpuw/Matpuw sin-
gle mutant RPE (40% of total melanosomes; Table 3). Therefore
melanosome maturation increased (P 0.01) in the absence of
both Oa1 and Matp, although the block of melanosome matu-
ration at stage III characterizing Matpuw/Matpuw single-mutant
RPE was retained.
Altogether these results suggested that Oa1 exerts a size
control function only on fully developed stage-IV melano-
somes, independent of melanin synthesis. Therefore, melano-
some maturation and not melanin deposition has a direct in-
fluence on the formation of macromelanosomes.
DISCUSSION
Two main classes of albinism that affect pigmentation in the
eye have been described: oculocutaneous albinism (OCA) and
ocular albinism (OA). In OCA hypopigmentation is caused by
inadequate melanization of an apparently normal number of
melanosomes, whereas OA was suggested to result from re-
duced number of melanosomes.25 Patients with OA1 have a
severe reduction of visual acuity, horizontal and rotary nystag-
mus, photophobia, and lack of stereoscopic vision due to
misrouting of the optic tract. A peculiar melanosome pheno-
type in these patients was characterized by the presence of
pigmented melanosomes with a giant size,23,25 suggesting that
the absence of OA1 could interfere with the normal melano-
some biogenesis. However, we still lack a comprehensive view
of how this phenotype is acquired and how it relates with the
albino phenotype observed in the RPE. In particular, it is
unclear how the presence of pigmented melanosomes recon-
ciles with the observed albino phenotype in the RPE, at which
stage(s) of melanosome maturation OA1 exerts its function,
and whether an impaired control of melanin synthesis and/or
of rate of melanosome biogenesis is involved in giant melano-
some formation. Our study addresses these important ques-
tions and allows defining the differences between OA (albinism
isolated to the eye) and OCA. We focused our attention on two
aspects of melanogenesis in the RPE: rate of melanosome
formation and size control. We found that these events are
both affected by lack of Oa1 activity.
We first characterized Oa1 interaction with Tyr and showed
that there is no impairment in Tyr activity and expression in
Oa1 mutant mice. This aspect of the phenotype differentiates
Oa1 from other albino mice in which melanin production is
affected.22 However, the number of mature melanosomes in
Oa1 mutant eyes was reduced by 50% in the RPE after birth.
This reduction was in the number of stage IV melanosomes. It
is possible that the effect on other melanosomal stages is
masked by the lower number of stage-II and -III organelles after
birth. In fact, a reduction in the number of stage-II mela-
nosomes was detected both in mutants when melanosome
maturation is impaired (Oa1/;Tyrc-2J/Tyrc-2J and Oa1/;
Matpuw/Matpuw double mutants) and at embryonic stages in
Oa1/ RPE. These results demonstrate, for the first time, that
the reduced pigmentation of the RPE observed in patients with
ocular albinism type 1 is caused by reduced number of pig-
mented melanosomes.
A second relevant aspect of Oa1 function highlighted by our
results is the specificity of Oa1 size control activity on stage-IV
melanosomes. This conclusion is based on the absence of
melanosome enlargement in the RPE of Oa1/;Tyrc-2J/Tyrc-2J
and Oa1/;Matpuw/Matpuw double-mutant mice which lack
stage-IV melanosomes and display either stage-II or -III, respec-
tively. Therefore, in the absence of fully mature melanosomes
Oa1 does not exert its size control function.
Whereas the Oa1 size control activity is specific for the
most mature melanosomes, an additional Oa1 function appears
to be exerted at earlier stages. In particular, in Oa1/ single
and double mutants, the number of stage-II melanosomes was
reduced at the earliest stages of maturation analyzed: E15.5 for
Oa1/, and P7 or 3-month postnatal stages for Oa1/;
Tyrc-2J/Tyrc-2J and Oa1/;Matpuw/Matpuw double mutants.
In contrast, stage-III melanosomes were more abundant in
Oa1/;Matpuw/Matpuw double mutants compared with
Matpuw/Matpuw single-mutant mice. This suggests that Oa1
may at the same time control the maturation rate of melano-
somes and inhibit the overgrowth of the most mature ones. In
agreement with this interpretation is our previous report of
OA1 acting as a negative regulator of melanosome matura-
tion.26 We cannot exclude, however, that the phenotype ob-
served in double-mutant mice could also be due to a specific
interaction between the two genes.
Although we have not defined the mechanisms by which
Oa1 may perform its double function, it is of note that hetero-
trimeric G-proteins associated with intracellular organelles
have been described to participate in various steps of secretion
and vesicular fusion27 and organelle maturation,28 even though
no specific intracellular GPCR has yet been described for these
functions. We suggest that Oa1 may act as a GPCR, either
constitutively active, or activated by melanin or a byproduct of
melanin synthesis that controls membrane delivery to the mela-
nosomes. This interpretation could explain the reduction of
early stage melanosomes and the macromelanosome pheno-
type.
Taken together, our findings indicate that Oa1 regulates
melanosome maturation. Acting at early maturation stages, Oa1
controls the abundance of melanosomes in RPE cells, and, at
later stages, Oa1 has a function in maintaining a correct mela-
nosomal size. The dissection of these two Oa1 activities allows
a better understanding of the albinism phenotype due to the
TABLE 3. Number of Melanosomes in RPE of Tyrc-2J/Tyrc-2J and
Oa1/; Tyrc-2J/Tyrc-2J Mutant Mice, and Matpuw/Matpuw and
Oa1/; Matpuw/Matpuw Mutant Mice
Stage
Area
(m2)II III IV
Tyrc-2J/Tyrc-2J
P7 97 0 0 355
Oa1/;Tyrc-2J/Tyrc-2J
P7 62 0 0 355
Matpuw/Matpuw
3 months 31 20 0 186
Oa1/;Matpuw/Matpuw
3 months 17 50 0 186
The total area of the cell analyzed (area) was determined by the
point-intersection method and expressed in square micrometers.29
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lack of this protein, and in the future it will be important in the
design therapeutic approaches for this disease.
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